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RIASSUNTO 
Il progetto di ricerca su cui ho svolto i miei studi è iniziato con lo scopo di individuare 
nuovi interattori di MuSK ed è proseguito con la caratterizzazione dei meccanismi in cui 
sono coinvolti. MuSK è un recettore tirosina chinasi, espresso nelle fibre muscolari, nelle 
quali regola lo sviluppo della giunzione neuromuscolare. Studi pubblicati negli ultimi 
anni, hanno dimostrato che MuSK non è coinvolto solo nella formazione iniziale della 
giunzione neuromuscolare, ma anche nel mantenimento dell’apparato postsinaptico e 
nel controllo della crescita assonale. 
La giunzione neuromuscolare trasmette segnali dai motoneuroni alle fibre muscolari 
multinucleate. Un fenomeno che caratterizza l’apparato postsinaptico, è l’aggregazione 
dei recettori dell’acetilcolina (AChR) (Sanes and Lichtman, 1999). Solo i nuclei 
muscolari a diretto contatto con la sinapsi, trascrivono i geni codificanti per le subunità 
del AChR (Merlie and Sanes, 1985). Normalmente, l’aggregazione degli AChRs, è 
indotta dalla proteina agrina, secreta dai motoneuroni, e dalle neoreguline. Studi 
dimostrano che queste ultime stimolano la trascrizione dei geni dell’AChR (Falls et al., 
1993). Esperimenti recenti indicano, comunque, che le neureguline non sono essenziali 
per la trascrizione sinapsi-specifica dei geni delle subunità del recettore, perché, in topi 
mancanti di ErbB2 ed ErbB4, selettivamente nel muscolo scheletrico, ed in quelli 
mancanti della neuregulina nei motoneuroni e nelle fibre muscolari, sono stati riscontrati 
fenotipi modesti o del tutto normali (Escher et al., 2005; Jaworski e Burden, 2006). Altri 
dati suggeriscono che il ruolo primario delle neureguline, nell’apparato postsinaptico, 
consiste nella regolazione dell’aggregazione e nella migrazione degli AChRs sulla 
superficie cellulare (Ponomareva et al., 2006). 
Le neureguline attivano i recettori tirosina chinasi della famiglia del recettore EGF 
(ErbBs). L’eterodimero ErbB2/4 è il recettore con maggiore funzionalità nell’apparato 
postsinaptico (Trinidad et al., 2000). Le proteine ErbB sono concentrate al sito 
postsinaptico della giunzione neuromuscolare (Altiok et al., 1995; Moscoso et al., 1995; 
Zhu et al., 1995; Trinidad et al., 2000) o nel sistema nervoso centrale (Garcia et al., 
2000; Huang et al., 2000). La localizzazione sinaptica di ErbB4 nel sistema nervoso 
centrale, è mediata da un’interazione del suo dominio carbossi–terminale con il dominio 
PDZ della proteina PSD-95 (Postsynaptic Density Protein) (Garcia et al., 2000; Huang et 
al., 2000). Al contrario, PSD-95, interagisce debolmente o per niente, con ErbB2 ed 
ErbB3.  
Un’altra proteina contenente un dominio PDZ, Erbin, interagisce specificatamente con 
ErbB2 (Borg et al., 2000; Huang et al., 2001). Erbin è la capostipite di una famiglia di 
proteine denominata LAP (Leucine-rich-repeats and PDZ domain), caratterizzate da 16 
ripetizioni “leucine-rich” (LRR) nella porzione amino-terminale e da 1 a 4 domini PDZ in 
quella carbossi–terminale (Borg et al., 2000). Tutte le proteine della famiglia LAP sono 
coinvolte nella determinazione della polarità cellulare (Bryant e Huwe, 2000; Kolch, 
2003). Di recente è stato dimostrato che, il dominio tra la LRR e il PDZ di Erbin, 
interagisce con EBP50 (Rangwala et al., 2005) e Smad3 (Dai et al., 2007). 
Il ruolo e le interazioni molecolari di Erbin nella giunzione neuromuscolare, non sono 
stati ancora studiati. In questo studio noi dimostriamo (1) che Erbin è localizzata alla 
giunzione neuromuscolare, (2) interazioni di Erbin con il recettore tirosina kinasi MuSK, 
che media l’azione dell’ agrina, come principale regolatore della formazione 
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dell’apparato postsinaptico, e con ErbB2, (3) che il dominio di Erbin interagente con 
MuSK, si sovrappone al dominio interagente con Smad3, (4) che Erbin o MuSk, 
attenuano la trascrizione mediata da Smad3.  
Tre diverse isoforme (splice variants) di Erbin sono state identificate in cellule muscolari, 
tutte contenenti il dominio di interazione con MuSK. Esperimenti di knockdown in cellule 
muscolari, attribuiscono ad Erbin un ruolo nel controllo della densità di aggregati di 
recettori dell’acetilcolina. In aggiunta ad Erbin, altre proteine della famiglia LAP sono 
state individuate nella giunzione neuromuscolare: Lano e Scribble. Il rate di trascrizione 
dei geni codificanti per queste 2 proteine, aumenta quando i mioblasti differenziano in 
miotubi. 
Il nostro scopo era di identificare, tramite yeast-two-hybrid screening, nuove proteine 
interagenti con il dominio intracellulare di MuSK. Per questo, abbiamo fuso 2 parti del 
dominio intracellulare del recettore (MuSK2xWT), creando così un dimero che 
somigliasse il più possibile al dimero di MuSK, conformazione attiva in vivo (Cheusova 
et al., 2006). Un secondo costrutto è stato generato allo stesso modo, ma per una 
variante di MuSK priva di attività chinasica, per capire se il legame con altre proteine 
fosse dipendente dalla fosforilazione del dominio intracellulare. L’espressione di questi 
costrutti, la loro funzionalità e la loro applicabilità allo screening, sono stati descritti 
precedentemente (Cheusova et al., 2006). 
Tra i cloni identificati, 2 consistevano della porzione carbossi-terminale dal residuo 
aminoacidico 1007 fino al codone di stop della isoforma umana di Erbin (hErbin-ND-
1007), proteina della famiglia LAP. Nell’uomo, sono state descritte diverse varianti di 
Erbin. Quella da noi identificata corrisponde alla porzione carbossi-terminale della 
variante 2 (hErbin-V2). La stessa interazione si è osservata  anche con la variante di 
MuSK priva di attività chinasica. 
Per confermare l’interazione con altri approcci sperimentali, abbiamo effettuato una 
transfezione transiente di cellule HEK293 dei vettori di espressione per Erbin, 
MuSK2xWT e la variante con inattivazione del dominio kinasico, gli ultimi 2 contenenti 
una T7-tag. Immunoprecipitati degli estratti proteici hanno confermato i dati 
precedentemente ottenuti.  
Per determinare se l’interazione fosse facilitata dall’over-espressione delle proteine, 
abbiamo effettuato immunoprecipitati da estratti proteici di una linea di cellule muscolari 
(C2C12) e da muscolo scheletrico (Gastrocnemius) murino. In queste condizioni, dove 
sia Erbin che MuSK sono endogenamente espressi allo stesso livello, è stato ancora 
possibile co-precipitare entrambe con i rispettivi partners. 
Poiché Erbin e MuSK interagiscono fisicamente, abbiamo voluto determinare il profilo di 
espressione di Erbin nelle regioni sinaptiche e post-sinaptiche. Attraverso RT-PCR 
abbiamo misurato la quantità di transcritto di Erbin e l’abbiamo paragonato a quello di 
proteine concentrate normalmente alla giunzione neuromuscolare (MuSK, AChR). 
L’RNA totale è stato estratto dalla regione sinaptica e quella extra-sinaptica del 
diaframma di topo. Come previsto, sia MuSK che AChR erano altamente espressi a 
livello della regione sinaptica, così come Erbin. L’espressione del transcritto di Erbin a 
livello sinaptico, è stata confermata anche da ibridazione in sito su diaframmi di topi. 
Il nostro obiettivo successivo era quello di dimostrare la localizzazione di Erbin 
nell’apparato postsinaptico. Attraverso tecniche di immunoistochimica su sezioni 
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trasversali dei muscoli gastrocnemius e soleus (zampe posteriori) di topo, abbiamo 
osservato un’accumulo significativo di Erbin alla giunzione neuromuscolare, dove co-
localizzava con i recettori dell’acetilcolina. 
Per identificare gli epitopi di MuSK ed Erbin che interagiscono tra loro, abbiamo usato 
una serie di mutanti di MuSK con delezioni nella porzione carbossi–terminale. 
Dapprima, nello screening yeast-two-hybrid, abbiamo osservato che i lieviti crescevano 
solo quando hErbin-N-1007 era usata come “esca” con i vettori “preda” contenenti i 
costrutti MuSK-515-868 e MuSK-515-857, che comprendono il dominio intracellulare di 
MuSK e il dominio chinasico, rispettivamente. Tramite esperimenti di GST pull down, 
l’interazione osservata con i lieviti, ha avuto un’ulteriore conferma. 
Il passo seguente è stato quello di procedere all’identificazione del dominio di hErbin-
NΔ-1007, interagente con MuSK. Anche in questo caso sono stati generati diversi 
mutanti, tramite delezioni, sia nella porzione amino-terminale, che in quella carbossi-
terminale. Solo i lieviti contenenti il frammento con delezione fino al residuo 
aminoacidico 1200 (hErbin-NΔ-1200), come hErbin-PDZ (hErbin-NΔ-1261), crescevano 
su terreno selettivo. In caso di delezioni nella parte carbossi-terminale, riuscivano a 
crescere solo i lieviti contenenti Erbin dal residuo aminoacidico 1007 fino al 1266 
(hErbin-ΔPDZ) o 1204 (hErbin-1007-1204). Gli epitopi identificati sono stati verificati 
anche in esperimenti di GST pull down.  
Avendo dimostrato che Erbin interagisce con MuSK, collegando quindi MuSK con 
ErbB2, abbiamo voluto investigare il significato biologico di questa interazione. 
L’approccio usato, è consistito nello studiare se l’ablazione o l’over-espressione di Erbin 
avesse una conseguenza sull’aggregazione dei recettori dell’acetilcolina. Per questo 
abbiamo clonato diversi vettori codificanti per shRNA, e testato la loro efficienza nel 
diminuire l’espressione dei trascritti di Erbin. Ciò è stato fatto sia mediante saggi di 
luciferasi, sia mediante western blot su lisati proteici di HEK293, transfettate con gli 
shRNAs. Allo scopo di analizzare l’effetto del knockdown di Erbin sugli aggregati, 
abbiamo transfettato cellule C2C12 con Erbin shRNA. Dopo aver stimolato 
l’aggregazione dei recettori, tramite aggiunta di agrina nel mezzo di coltura, abbiamo 
incubato le cellule con la bungarotossina coniugata alla rodamina. Grazie all’alta affinità 
di legame della tossina verso la subunità alfa dei recettori, è possibile osservarli tramite 
fluorescenza. Livelli minori del trascritto di Erbin riducono significativamente la densità 
dei recettori. L’analisi della densità è stata effettuata tramite microscopia confocale. 
Di recente è stato dimostrato che Erbin inibisce la cascata di segnali di TGF-β attraverso 
un dominio interagente con Smad (Dai et al., 2007). Era di nostro interesse sapere se le 
cellule C2C12 esprimessero TGF-β e Smad, e se questo accadesse in dipendenza o 
meno dall’agrina. Tramite RT-PCR abbiamo dimostrato l’espressione dei recettori TGF-
 β RI e TGF- β RII e Smad3 nelle cellule muscolari. Per identificare il ruolo di Erbin e 
MuSK nel signaling di TGF- β abbiamo transfettato C2C12 con un vettore di espressione 
codificante per Smad3. Abbiamo osservato, come riportato in letteratura (Liu et al., 
2001) che questa proteina inibiva la differenziazione dei mioblasti in miotubi. Noi 
dimostriamo che, la co-transfezione di Smad3 con hErbin-v2, blocca l’inibizione e i 
mioblasti riescono a differenziarsi nuovamente.  
Per identificare la presenza di altre proteine della famiglia LAP in cellule muscolari, 
abbiamo eseguito esperimenti di RT-PCR su mioblasti e miotubi C2C12. Abbiamo così 
12 
 
individuato la presenza di Scribble e Lano. Un altro dato interessante è che 
l’espressione di Scribble è di gran lunga maggiore di quella di Lano e si osserva un suo 
ulteriore aumento dopo stimolazione dell’aggregazione dei recettori, tramite agrina. 
Al momento è in corso lo studio dell’effetto che il knockdown di Scribble e Lano, anche 
in combinazione con quello di Erbin, ha sulla densità degli aggregati dei recettori. 
Stiamo valutando gli stessi effetti anche su colture primarie di muscolo scheletrico, a 
seguito del knockdown delle suddette proteine. 
I nostri dati dimostrano per la prima volta un’interazione tra Erbin e MuSK a livello della 
giunzione neuromuscolare e presentano un inizio per un approfondimento del ruolo 
delle proteine LAP nell’apparato postsinaptico.   
L’identificazione di interazione tra proteine è un prerequisito per lo studio di meccanismi 
di signaling. Lo stato dell’arte riguardante la trasduzione del segnale della giunzione 
neuromuscolare è molto limitato. L’identificazione di interazioni alla giunzione, può dare 
la possibilità di conoscere meglio lo sviluppo e le patologie della sinapsi. Per esempio, 
dati recenti riguardo l’interazione tra MuSK e la porzione C-terminale di Co1Q, una 
“coda” collagenica che trasporta l’Acetilcolinesterasi alla giunzione neuromuscolare, 
hanno dimostrato che MuSK è responsabile della localizzazione sinaptica dell’esterasi, 
ed hanno dato spiegazioni per certe forme di sindromi di miastenia congenita, associate 
con mutazioni nella parte C-terminale di Co1Q (Engel et al., 2003). 
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1. Introduction 
1.1. Synapse 
The word synapse first appeared in 1897, in the seventh edition of Michael Foster’s 
Textbook of Physiology and describes the point of contact between two cells. Synapses 
are specialized structural units for cellular communication in the nervous system. The 
formation of synapses requires a series of steps. First, the parts of the two cells have to 
migrate to the place where the synapse will form. Second, these subcellular structures 
of the cells have to differentiate to specialized presynaptic terminals and postsynaptic 
membranes (Bowe and Fallon, 1995). Much of the knowledge about synapses came 
from the study of neuromuscular junctions. 
 
1.2. Neuromuscular junction 
The neuromuscular junction (NMJ) is a synapse composed by a specialized part of a 
motoneuron and a muscle fiber (Hall and Sanes, 1993). The NMJ consists of the 
presynaptic nerve terminal, the postsynaptic muscle fiber and the presynaptic Schwann 
cells (PSCs, also known as “terminal” Schwann cells). Additionally between the nerve 
terminal and the muscle membrane, a synaptic basal lamina develops, which is 
composed of extracellular matrix and factors produced and secreted by both nerve and 
muscle (Bloch and Pumplin, 1988; Sanes and Lichtman, 1999). 
Neuromuscular junctions have been widely used for analyses of synaptic 
structure,function and development because of several advantages over the synapses 
from thecentral nervous system (Burden, 1998; Sanes and Lichtman, 1999; Wyatt and 
Balice-Gordon, 2003), namely size, accessibility and simplicity. 
 
1.2.1. Development of the neuromuscular junction 
During development starting at about embryonic day (E) 11 in mice multinucleated 
skeletal muscle fibers form by fusion of precursor myoblasts. Shortly after myotubes 
begin to form (at E12-13 in mice), motoneurons begin to contact muscle cells (Fig.1). 
Motoneurons can innervate from one to over hundred muscle fibers, but each muscle 
fiber receives input from only one motoneuron. In the terminal branches of the motor 
nerve, at dense patches called active zones synaptic vesicles filled with the 
neurotransmitter acetylcholine (ACh) start to accumulate (Hall and Sanes, 1993). 
At E14 first signs of postsynaptic specialization indicated by the aggregation of 
acetylcholine receptor (AChR) clusters appear on the surface of muscle fibers. Nerve 
terminal and muscle fiber continue development in the later embryonic stages. At birth, 
both nerve terminal and opposite areas of muscle fiber are greatly transformed and 
havenearly accomplished their pre- and postsynaptic specialization. All inputs of motor 
axon to the muscle fibers except one are withdrawn during early postnatal life. 
Embryonic AChRs containing a γ subunits (α2βγδ) are replaced by AChRs containing ε 
subunits (α2βεδ) during the first postnatal weeks (Mishina et al., 1986; Witzemann et al., 
1989). 
AChRs appear first as a patch-like pattern but further differentiates by time into a 
characteristically shaped ‘‘pretzel-like’’ pattern. 
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Fig.1: Development of the neuromuscular junction. 
The motor axon approaches a newly formed myotube. At the area of contact, the axon 
differentiates into a motor nerve terminal that is specialized for transmitter release, 
Schwann cell processes cap the terminal, and the muscle forms a complex postsynaptic 
apparatus. Acetylcholine receptors (AChRs) are initially present at a moderate level 
throughout the myotube surface. In adult muscle, by contrast, AChRs are highly 
concentrated in the postsynaptic membrane and virtually absent extrasynaptically. This 
clustering involves both redistribution of AChR proteins, and localized synaptic synthesis 
of AChRs. Modified from (Sanes and Lichtman,2001). 
 
The postsynaptic membrane is invaginated into deep and regular folds, termed 
postjunctional folds (Fig.1). AChRs and additional proteins are localized to the crests of 
these postjunctional folds, whereas other proteins, including sodium channels, are 
enriched in the troughs of the postjunctional folds (Hall and Sanes, 1993). 
As the postsynaptic membrane matures, the presynaptic terminal also differentiates 
dramatically. Synaptic vesicles become clustered at the active zones and the nerve 
terminal becomes polarized (Hall and Sanes, 1993). Active zones aligned precisely with 
the postjunctional folds. This precise alignment of active zones and postjunctional folds 
ensures that acetylcholine encounters a high concentration of AChRs within 
microseconds after release, thereby ensuring fast synaptic transmission (Hall and 
Sanes, 
1993). 
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1.3. Clustering of AChRs 
Clustering of AChRs in the postsynaptic membrane is critical for synaptic function, as a 
high density of synaptic AChRs is required to generate a synaptic potential of sufficient 
magnitude to initiate an action potential in the myofiber. Early in development AChRs 
are evenly distributed in the plasma membrane of myotubes at a density of 1000/μm2. 
As synapse formation proceeds, the concentration of AChRs reaches 10,000/μm2 in the 
postsynaptic membrane and falls to 10/μm2 in extrasynaptic areas of the myotube 
(Fertuck and Salpeter, 1974; Bevan and Steinbach, 1977). This higher density of AChRs 
at the subsynaptic membrane is achieved through: 
1. clustering of preformed synaptic nuclei (Couteaux, 1963);  
2. specialization of subsynaptic nuclei for AChR subunit genes transcription (Merlie 
and Sanes, 1985; Burden, 1993; Moscoso et al., 1995); 
3. suppression of AChR subunit genes transcription in the extrasynaptic area by 
electric activity (Lomo and Westgaard, 1975; Fambrough, 1979; Schaeffer et al., 
2001);  
4. formation of new AChR clusters (Frank and Fischbach, 1979); 
5. redistribution of AChRs from the extrasynaptic to synaptic sites (Ziskind-Conhaim 
et al., 1984); 
6. lateral diffusion trap of receptors in the membrane (Edwards and Frisch, 1976; 
Phillips et al., 1993) involving cholesterol-rich lipid microdomains for 
enhancement of their stabilization through increased phosphorylation (Willmann 
et al., 2006); 
7. increased stability of synaptic proteins within the cluster (Fambrough, 1979). 
AChR clustering is thought to be controlled by nerve derived signals that act through 
different mechanisms (Burden, 2002). The proteoglycan agrin induces the aggregation 
of AChRs distributed diffusely in the plane of the membrane (McMahan, 1990). Agrin 
has also been proposed as the signal activating selective AChR transcription in 
myonuclei at the synaptic site (Meier et al., 1998; Lacazette et al., 2003). For a long time 
it was believed that neuregulin activate local transcription of AChR subunit genes 
(Fischbach and Rosen, 1997). However recent evidences have changed this belief 
(Yang et al., 2001; Escher et al., 2005) awarding agrin the main role in both transcription 
and clustering of AChR. Neurotransmitter ACh suppresses AChR transcription 
extrasynaptically (Lin et al., 2005). 
 
1.3.1. Agrin 
Agrin was purified from Basal lamina (BL) fractions from the electric organ of the 
Torpedo californica as a factor which aggregates AChR in cultured myotubes (Godfrey 
et al., 1984; Wallace et al., 1985). Further studies revealed that agrin is synthesized by 
motor neurons, transported down their axons, released into the synaptic cleft and stably 
integrated into the synaptic BL (Magill-Solc and McMahan, 1988,1990). Based on these 
findings, McMahan proposed the ‘agrin hypothesis’, which states that agrin is a nerve-
derived postsynaptic organizing molecule (McMahan, 1990). 
In order to verify the validity of the agrin hypothesis in vivo, mice with targeted deletion 
of agrin were generated (Gautam et al., 1996). Mice lacking agrin die at birth and display 
dramatically fewer AChR clusters at the NMJ (Gautam et al., 1996). The near absence 
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of AChR clusters in agrin deficient mice lends credibility to the idea that agrin is a key 
inducer of postsynaptic differentiation. This hypothesis is further strengthen by ectopic 
expression of agrin in skeletal muscle leading to new clusters of synaptic proteins 
(Cohen et al., 1997; Jones et al., 1997; Rimer et al., 1997). 
The agrin gene encodes a protein of more than 2,000 amino acids with a predicted 
molecular mass of 225 kd (Fig.2). The extensive N-and O-linked glycosylation of the 
amino-terminal half increases the apparent molecular mass of agrin to ~600 kDa (Fig.2). 
Agrin has several isoforms generated by alternative RNA splicing with distinct biological 
activity and tissue distribution (see. Table. 1.1). The isoforms that contain inserts in Y 
and Z sites in rodents have higher biological clustering activity (Ferns et al., 1992; 
Ruegg et al., 1992; Ferns et al., 1993; Gesemann et al., 1995). Agrin molecules with an 
eight amino acid insertion at Z position are at least 10,000 fold more active than agrins 
lacking this insertion (Ruegg et al., 1992; Ferns et al., 1993). A four amino acid insertion 
at the Y position caused a modest additional increase in the activity of agrin having an 
insertion at the Z position, and the Y insertion also seems to be involved in the binding 
of agrin to heparin and proteoglycans (Ferns et al., 1993; Hoch et al., 1994a). 
 
 
Fig. 2: Schematic representation of the structural domains predicted by the agrin cDNA. 
The protein modules are represented by the boxes indicated. The sites for alternative 
mRNA splicing with the possible number of amino acids are shown below the domain 
structure. Modified from (Kroger and Schroder, 2002). 
 
Agrin synthesized by the nerve is spliced differently from muscle derived agrin isoforms 
and is of much greater importance for the induction of synapses than its muscle derived 
counterpart (Ruegg et al., 1992);  
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1.  AChR clustering activity of nerve derived agrin is approximately 1000 fold higher 
than that of the muscle derived isoforms (Cohen and Godfrey, 1992; Ruegg et 
al., 1992; Ferns et al., 1993; Hoch et al., 1993);  
2.  NMJs in mice lacking nerve derived agrin, but not muscle derived agrin, 
resemble NMJs in mice lacking all forms of agrin (Burgess et al., 1999). 
Agrin induced clustering of AChR involves the co-clustering of multiple associated 
proteins, several of which have been identified to date (Sanes and Lichtman, 
1999,2001). These include the muscle specific receptor tyrosine kinase (MuSK) (Glass 
et al., 1996b), the linker protein rapsyn (Apel et al., 1997) and the scaffolding proteins 
dystroglycan and utrophin (Jacobson et al., 2001). 
 
 
 
 
 
Table. 1.1: Tissue distribution of different agrin isoforms. Modified from (Bezakova and 
Ruegg, 2003). 
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More recently, the agrin hypothesis was challenged when two groups noted that some 
AChRs cluster in the absence of nerves (Anderson and Cohen, 1977; Frank and 
Fischbach, 1979; Lin et al., 2001; Yang et al., 2001). They found out that in embryonic 
day (E) 14.5 diaphragm muscles of wild type mice many of the AChR clusters confined 
to the center of the muscle are aneural. However, all clusters found at E16.5 in wild-type 
muscles are innervated (Lin et al., 2001). In addition, in the absence of both 
motornerves and agrin AChR clusters still formed (Lin et al., 2001). Remarkably, these 
AChR clusters localize to the central region of the diaphragm where the end-plate band 
would have formed (Lin et al., 2001). A close examination of agrin deficient mice 
revealed that prior to motor axon invasion of the myotome, AChR clusters initially form, 
but in the absence of agrin are not maintained (Lin et al., 2001). 
These studies suggested two different possibilities:  
1. some AChR clusters form aneurally in the absence of nerve derived agrin;  
2. agrin may be required to stabilize the aneural clusters after axon myotube 
contact. 
Secondly, a pair of studies revealed that acetylcholine (ACh) acts as a destabilizing 
factor on AChR clusters, and that agrin counterbalances this by stabilizing clustered 
AChRs (Lin et al., 2005; Misgeld et al., 2005). These studies revealed that AChR 
clusters initially form in agrin mutants, but as ACh is released, these clusters largely 
diffuse. 
Genetic removal of ACh from agrin deficient mutants by deleting the enzyme 
responsible for generating ACh partially rescues the postsynaptic phenotype in these 
mice (Lin et al., 2005; Misgeld et al., 2005). 
The dispersal mechanism of AChR remains to be clarified, but involves activation of the 
cytoplasmic kinase Cdk5 (Fu et al., 2005; Lin et al., 2005). 
 
1.3.2. Muscle specific kinase (MuSK) 
MuSK is a receptor tyrosine kinase supposed to be expressed specifically by skeletal 
muscle during synapse formation (Valenzuela et al., 1995; Glass et al., 1996b). A link 
between MuSK and in vitro by agrin induced postsynaptic differentiation is believed 
because of the following observations:  
1. MuSK deficient myotubes failed to form AChR clusters in the presence of agrin,  
2. a soluble, extracellular fragment of MuSK neutralized the ability of agrin to induce 
AChR clustering (Glass et al., 1996b; Glass et al., 1997),  
3. AChR clusters can induce independently of agrin in cultured myotubes by the 
addition of anti-MuSK antibodies (Xie et al., 1997; Hopf and Hoch, 1998). 
Supporting an in vivo role of MuSK in agrin signaling, genetic removal of MuSK results 
in mice that phenotypically resemble agrin deficient mice (DeChiara et al., 1996). MuSK 
-/- mice die at birth and show no AChR clustering at all stages of embryonic 
development (DeChiara et al., 1996; Gautam et al., 1999). Generation of MuSK 
conditional mice demonstrated that MuSK is required not only for the initial formation of 
AChR clusters in embryogenesis but also throughout postnatal development to maintain 
postsynaptic apparatus and to control axonal growth (Hesser et al., 2006). Although it is 
obvious to assume that MuSK is the agrin receptor, agrin does not bind MuSK directly. 
Because agrin induces activation of MuSK in muscle cells but not in fibroblasts, and 
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because binding assays have generally failed to demonstrate direct interactions 
between the two proteins, a muscle cell surface component known as myotube 
associated specificity component (MASC) has been hypothesized. This hypothetical 
component is believed to be co-expressed on muscle surfaces with MuSK and to form 
together with MuSK the agrin receptor (Glass et al., 1996; Glass et al., 1997). 
Recombinant agrin added to myotubes can be cross-linked to MuSK on muscle 
surfaces, demonstrating the existence of a MuSK/agrin complex (Glass et al., 1996a; 
Glass et al., 1997). 
The additional myotube specific component(s) are not known but could include: 
1. a membrane protein that binds agrin and acts as a true agrin receptor (Jing et al., 
1996);  
2. a co-ligand that acts with agrin to bind and activate MuSK (Klagsbrun and Baird, 
1991; Lopez-Casillas et al., 1991; Rapraeger et al., 1991; Ferns et al., 1993; 
Aviezer et al., 1994);  
3. posttranslational modifications of MuSK that allow agrin to bind directly to MuSK 
(Binari et al., 1997). 
Consistent with the latter possibility, certain glycosyltransferases are expressed 
selectively at synaptic sites in skeletal muscle (Scott et al., 1990), resulting in the 
concentration of certain carbohydrate epitopes, attached to proteins, at neuromuscular 
synapses (Scott et al., 1988). One such epitope is the cytotoxic T cell (CT) antigen, 
which is selectively expressed at both the pre- and postsynaptic sides of the NMJ. The 
CT antigen is an unusual modification in which a terminally sialylated galactosamine 
residue is further modified with an N-acetylgalactosamine by the CT GalNAc transferase 
(Martin, 2002). Neural agrin can induce autophosphorylation of immunopurified MuSK in 
the presence of carbohydrate precursors of the CT epitope, and expression of the CT 
transferase in HEK cells can increase MuSK phosphorylation in the presence of agrin 
(Parkhomovskiy et al., 2000). These results suggest that the CT antigen could comprise 
the MASC hypothesized to be necessary for agrin/MuSK binding. In support of this, it 
has recently been reported that agrin itself can bear the CT epitope (Xia and Martin, 
2002). 
The extracellular region of mammalian MuSK contain four immunoglobulin like domains 
and a cysteine-rich domain (Fig.3); in avian, fish and amphibians, the extracellular 
region also contains a kringle domain (Jennings et al., 1993; Valenzuela et al., 1995; Fu 
et al., 1999; Ip et al., 2000). The first Ig-like domain is required for agrin responsiveness 
(Zhou et al., 1999). MuSK mutants without the fourth Ig-like domain don’t co-cluster with 
rapsyn, suggesting that this domain may be involved in interacting with rapsyn (indirectly 
via a hypothetic protein RATL, for rapsyn associated transmembrane linker) (Apel et al., 
1995). Other noticeable domains include a conserved cysteine rich domain (CRD) 
known as C6-box, which shows homology to frizzled, a wnt receptor (Masiakowski and 
Yancopoulos, 1998; Saldanha et al., 1998) and a kringle domain of unknown function 
that is present in MuSK of torpedo, chick and Xenopus but absent from mammalian 
homologues (Jennings et al., 1993; Fu et al., 1999; Ip et al., 2000). 
The intracellular region of MuSK contains a 50 amino acid juxtamembrane domain, a 
kinase domain and a short, eight amino acid carboxyterminal tail (Fig.3). The C-terminus 
of MuSK contains the consensus sequence for binding to PDZ domains (Fig.3). 
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However, MuSK mutants with a deletion of the PDZ binding motif are still able to cluster 
AChRs (Zhou et al., 1999; Herbst and Burden, 2000; Herbst et al., 2002). 
 
Fig.3: Schematic structure of MuSK. Modified from (Willmann and Fuhrer, 2002) 
 
Stimulation of MuSK by agrin leads to: (1) the clustering of muscle derived proteins, 
likeMuSK, AChRs and ErbBs, (2) activation of synapse-specific gene expression, (3) 
induction of a retrograde signal for presynaptic and postsynaptic differentiation 
(DeChiara et al., 1996; Gautam et al., 1996) and (4) stimulation of rapid phosphorylation 
of MuSK. The kinase activity of MuSK is essential to stimulate clustering and tyrosine 
phosphorylation of AChR β- and δ-subunits. MAP kinase, PI3-kinase and PLC gamma 
signaling pathways are neither activated nor required by agrin/MuSK signaling to 
stimulate AChR clustering (Wallace, 1988; Herbst and Burden, 2000). 
MuSK contains nineteen intracellular tyrosine residues. Six of the nineteen are 
phosphorylated in activated MuSK: the juxtamembrane tyrosine (Y553), the tyrosines 
within the activation loop (A loop) (Y750, Y754, and Y755), a tyrosine near the beginning 
of the kinase domain (Y576), and a tyrosine (Y812) within the C-terminal lope of the 
kinase domain (Watty et al., 2000). These phophorylated tyrosines may act as docking 
sites for signal transducing molecules (Watty et al., 2000). Mutation of all three tyrosines 
in A loop destroys AChR clustering (Herbst and Burden, 2000) and each A loop 
autophosphorylation incrementally increases catalytic efficiency (Wei et al., 1995; 
Favelyukis et al., 2001). Ty-553, an autophophorylation site in the Juxtamembrane 
region of MuSK (Watty et al., 2000), also appear to be important for kinase activation; a 
Tyr-553 → Phe mutant form of MuSK does not undergo A loop autophosphorylation in 
vivo (Herbst and Burden, 2000). Tyr-553 is part of a consensus sequence (NPXY) for 
phosphotyrosine-binding (PTB) domain (Hopf and Hoch, 1998b). This segment of the 
MuSK juxtamembrane region has been shown to be essential for downstream signaling. 
A chimeric receptor containing only this segment of MuSK in the context of the 
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cytoplasmic domain from the RTK TrkA is capable of inducing AChR clustering upon 
agrin stimulation (Herbst and Burden, 2000). Kinase domain of MuSK is important for 
proper orientation of NPXY motif in the JM domain of MuSK (Till et al., 2002). 
Activated MuSK clusters MuSK (Jones et al., 1999; Moore et al., 2001), and this positive 
feedback mechanism may be important to achieve an adequate level of MuSK 
expression at the synapse, sufficient to cluster more than 10 million AChR molecules 
per synapse. 
Moreover, MuSK is unusual among receptor tyrosine kinases because its kinase activity 
is not sufficient to mediate all aspects of agrin responsiveness, primarily as measured by 
AChR clustering (Glass et al., 1997): a chimera composed of the neurotrophin receptor 
(trkC kinase) ectodomain fused to the MuSK cytoplasmic domain is activated by 
neurotrophin, but does not induce AChR clustering (Glass et al., 1997; Jones et al., 
1999). 
Thus, the MuSK ectodomain appears to play roles in addition to that of ligand binding. 
MuSK ectodomain may help to activate parallel signaling pathway or recruit other critical 
organizing components of the NMJ to a developing scaffold. 
 
1.4. Signaling downstream of MuSK 
1.4.1. Src kinases 
Agrin induces tyrosine phosphorylation of the AChR β- and δ-subunits (Wallace et al., 
1991; Qu and Huganir, 1994; Ferns et al., 1996). However tyrosine phosphorylation 
ofAChR is not sufficient to cluster AChRs (Glass et al., 1997). Moreover, mutant AChRs 
lacking cytoplasmic tyrosine residues in β-subunits can still be recruited into clusters in 
muscle cells (Meyer and Wallace, 1998). It is thought that tyrosine phosphorylation 
facilitates the interaction of AChRs with cytoskeletal proteins such as F-actin (Dai et al., 
2000), leading to focal accumulation of AChR through lateral diffusion. Inhibition of 
tyrosine phosphorylation of the β-subunit attenuates AChR clustering and increases 
AChR detergent extractability (Fuhrer and Hall, 1996; Borges and Ferns, 2001; 
Mohamed et al., 2001). A down stream kinase appears to be essential for agrin 
mediated signaling, since staurosprine blocks agrin induced AChR clustering and 
phosphorylation without inhibiting MuSK phosphorylation (Wallace, 1994; Fuhrer et al., 
1997). This kinase may be a member of the Src family kinases (SFKs (Fuhrer and Hall, 
1996). Indeed, agrin causes rapid activation of Src-related kinases (Mittaud et al., 2001). 
Agrin activation of Src or Src-like kinases requires rapsyn (Mohamed and Swope, 1999; 
Borges and Ferns, 2001; Mittaud et al., 2001; Mohamed et al., 2001). SFKs bind to and 
phosphorylate the nicotinic acetylcholine receptor of skeletal muscle (Fig.5 (Mohamed et 
al., 2001). The association of the receptor with the SFKs is mediated by high affinity 
binding of AChR subunit to the Src homology 2 (SH2) domains of the kinases (Swope 
and Huganir, 1994). Studies of mutant mice indicate that Src, Fyn, and Yes are not 
required for the formation of AChR clusters but are necessary for stabilization of agrin 
induced clusters (Smith et al., 2001). They act by holding postsynaptic proteins together 
in clusters through stabilization of rapsyn-AChR interaction and AChR phosphorylation. 
In addition they control rapsyn protein levels and AChR cytoskeletal linkage (Sadasivam 
et al., 2005). 
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1.4.2. Rho-family GTPases 
Rho GTPases function in regulating the cytoskeleton in various cells. AChR clusters are 
tightly associated with selective cell cytoskeletal proteins, either directly or indirectly, 
including actin (Lubit, 1984; Walker et al., 1985; Bloch, 1986; Hoch et al., 1994; Phillips, 
1995; Bloch et al., 1997). Actin polymerization may be directly involved in AChR 
clustering in cultured Xenopus muscle cells (Dai et al., 2000). It was found that Cdc42 
and Rac1 are activated by agrin, and inhibition of Cdc42 or Rac blocks agrin induced 
AChR clustering (Weston et al., 2000). Rac1 may be necessary for the initialphase of 
agrin induced AChR cluster formation and Rho activation crucial for the subsequent 
condensation of microclusters into full size AChR clusters (Weston et al., 2003). Studies 
suggest that downstream of the small GTPases may be p21-activated kinase (PAK), a 
cytoplasmic kinase involved in cytoskeleton regulation (Luo et al., 2002). PAK in muscle 
cells is activated by agrin in a manner dependent on Cdc42 or Rac1 and inhibition of 
PAK attenuates agrin/MuSK mediated AChR clusterin (Luo et al., 2002).  
 
 
Fig. 5: Agrin induced signaling cascades leading to assembly of the postsynaptic 
membrane at the NMJ. In the absence of nerve-derived agrin, at least two pre-
assembled signaling complexes (AChR complex and a MuSK complex) exist in the 
muscle membrane. Agrin causes rapid activation of MuSK, which triggers downstream 
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signaling cascades with the involvement of calcium, Rac, Cdc42, NO, and actin. Upon 
agrin stimulation Src/Fyn kinases phosphorylate MuSK and AChRs. Preassembled 
AChR complexes bind to the MuSK complex through rapsyn. Dystrophin/utrophin 
glycoprotein complex (D/UGC) is additionally recruited, stabilizing the entire 
postsynaptic apparatus. α -DG, α -dystroglycan; p, tyrosine phosphorylation. Modified 
from (Huh and Fuhrer, 2002). 
1.5. MuSK interacting proteins 
1.5.1. MAGI-1c 
Analysis of proteins associated with MuSK in Torpedo electric organ by cross-linking 
identified MAGI-1c (Strochlic et al., 2001). MAGI-1c is a membrane associated 
guanylate kinase (MAGUK) with inverted domain organization. By analogy with CNS 
synapses where MAGUKs play a primary role as scaffolding proteins that organize 
cytoskeletal signaling complexes at excitatory synapses (Fanning and Anderson,1999), 
likewise, MAGI-1c might be involved in the formation of a specialized protein complex at 
the NMJ participating to the terminal differentiation of the NMJ (Strochlic et al., 2001). 
1.5.2. Synaptic nuclear envelope-1 (Syne-1) 
Synaptic nuclear envelope-1 (Syne-1) was identified in yeast-two-hybrid screens using 
cytoplasmic domain of MuSK (Apel et al., 2000; Grady et al., 2005). Syne-1 is 
selectively associated with synaptic nuclei. Its location and structure raise the possibility 
that Syne-1 may be involved in the formation or maintenance of nuclear aggregates at 
the neuromuscular junction (Apel et al., 2000; Grady et al., 2005). 
 
1.5.3. Dishevelled 
Dishevelled was discovered through yeast-two-hybrid screen using the entire 
cytoplasmic region of MuSK as bait (Luo et al., 2002). Dishevelled is a cytoplasmic 
protein which contains three conserved domains: DIX (Dishevelled Axin), PDZ and DEP 
(Dishevelled- Egl-10 Pleckstrin) (Cadigan and Nusse, 1997; Dale, 1998). MuSK 
interacts directly via the JM and kinase domain with the DEP domain of Dishevelled. 
Dishevelled mutant that did not interact with MuSK inhibited the ability of agrin to induce 
AChR clustering indicating that agrin induced AChR clustering involves the Dvl-MuSK 
interaction (Luo et al., 2002). Dishevelled also interacts with the serine/threonine kinase 
PAK1 (p21-Activated Kinase) and involve in agrin induced activation of PAK1 in muscle 
cells (Luo et al., 2002). PAK1 is an effector of Rac and Cdc42 in actin reorganization. 
Dishevelled, by forming a scaffold with MuSK and PAK1, would thus regulate AChR 
clustering mediated by agrin (Luo et al., 2002). 
 
1.5.4. CollagenQ (ColQ)/Acetylcholinesterase (AChE) 
At the NMJ, AChE is present as asymmetric three tetramers of catalytic subunits which 
are associated with a structural collagenic tail named ColQ (Legay, 2000). ColQ is 
responsible for the accumulation of AChE in the synaptic basal lamina (Arikawa- 
Hirasawa et al., 2002). MuSK is also responsible for the accumulation of AChE at the 
synapse. In MuSK-/- mouse AChE doesn’t cluster (DeChiara et al., 1996) and MuSK 
injected ectopically in soleus muscle induces the formation of AChE clusters (Sander et 
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al., 2001). MuSK and ColQ can be cross-linked in situ in Torpedo AChR-rich 
membranes. Both proteins colocalize and coimmunoprecipitate in COS-7 cells after 
ectopic expression. Moreover, MuSK is required to form cell surface AChE clusters in 
cultured myotubes (Cartaud et al., 2004). 
 
1.5.5. Src homology 2-domain-containing tyrosine phosphatase 2 (Shp2) 
Tyrosine phosphatases interact with MuSK and regulate its tyrosine phosphorylation. It 
helps to define the AChR boundaries and dispersal of hot spot (Madhavan et al., 2005). 
For functional MuSK activation in muscle cells tyrosine phosphatase inhibition is 
sufficient (Meier et al., 1995). Shp2 is a tyrosine phosphatase which expresses in 
skeletal muscle and localize at NMJs (Tanowitz et al., 1999). MuSK interacts specifically 
with Shp2; however the depletion of Shp2 cannot activate MuSK maximally. Which 
suggest other tyrosine phosphatases might be involved in regulating MuSK activity 
(Madhavan et al., 2005). 
 
1.5.6. 14-3-3γ 
14-3-3γ was identified through chemical cross-linking experiments in purified 
postsynaptic membrane from Torpedo electrocytes. The 14-3-3γ protein co-localizes 
with+ AChRs at the NMJ in rat muscles and coimmunoprecipitates with MuSK (Strochlic 
et al., 2004). 14-3-3 proteins constitute an emerging family of signaling molecules 
present in eukaryotic organisms involved in intracellular signaling (van Hemert et al., 
2001). Over expression of 14-3-3γ in muscle cells specifically represses transcription of 
several synaptic genes including α-, δ- and ε-AChR subunits, utrophin, rapsyn and 
MuSK. The 14-3-3 proteins are known to interact and modulate the activity of Raf-1 (Fu 
et al., 1994). 14-3-3γ represses synaptic gene transcription by interfering with the 
MAPK/PI3 signaling pathways activated through NRG/ErbB (Tansey et al., 1996; Altiok 
et al., 1997). 14-3-3γ does not play a significant role in the clustering of AChR (Strochlic 
et al., 2004). In vivo 14-3-3γ expression in muscle fiber display severe morphological 
perturbations of the NMJ (Strochlic et al., 2004). Interaction of MuSK with 14-3-3γ 
suggests the involvement of MuSK in the regulation of synaptic gene expression at the 
NMJ. Consequently, inhibition of the ε-AChR subunit expression is more effective when 
14-3-3γ and MuSK were co-expressed then when the 14-3-3γ was expressed alone 
(Strochlic et al., 2004). 
 
1.5.7. Abelson tyrosine kinases (Abl) 
Abl1 and Abl2 (also known as Abelson and Arg respectively) are non-receptor tyrosine 
kinases. They have SH2 and SH3, a tyrosine kinase and a unique C-terminal actin 
binding domain (Van Etten et al., 1994; Wang et al., 2001; Pendergast, 2002). They are 
involved in reorganization of cytoskeleton (Lanier and Gertler, 2000; Pendergast, 2002). 
In Drosophila Abl kinases are involved in axon guidance (Wills et al., 1999a; Wills et al., 
1999; Lanier and Gertler, 2000; Pendergast, 2002). Abl kinases are localized to the 
postsynaptic membrane of neuromuscular junction (Finn et al., 2003). Expression of Abl 
kinases increases during development as has been shown for MuSK and Rapsyn (Finn 
et al., 2003). Abl kinases interact with MuSK and phosphorylate it which can either 
increase the kinase activity of MuSK or create new docking sites for signaling molecules 
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downstream of MuSK. In turn MuSK also phophorylate Abl kinases. Blocking of Abl 
kinases in C2C12 myotubes effects agrin induce acetylcholine receptor clustering (Finn 
et al., 2003). 
 
1.5.8. Geranylgeranyltransferase 1 (GGT-1) 
GGT is involved in prenylation (Zhang and Casey, 1996). Prenylation is the addition of 
prenyl molecules to a protein to enable its attachment to the cell membrane. MuSK 
interacts with α G/F subunit of GGT through its kinase domain (Luo et al., 2003) which 
result in an increase in tyrosine phophorylation of α G/F subunit. Increase in tyrosine 
phosphorylation of GGT correlate with its increase activity (Luo et al., 2003). Activation 
of Rac1 and the subsequent activation of PAK1 require prenylation by GGT (Luo et al., 
2003). Inhibition of GGT lead to attenuation in agrin induced activation of Rho-GTPases, 
AChR clustering and NMJ formation (Luo et al., 2003). 
 
1.5.9. Protein interacting with C kinase (PICK1) 
PICK1 was originally isolated due to its interaction with protein kinase C α (PKCα) 
(Staudinger et al., 1995; Staudinger et al., 1997). PICK1, a PDZ domain containing 
protein, interacts with the C termini of α-amino-3- hydroxy-5-methyl-isoxazole-4- 
propionic acid (AMPA) receptors at excitatory synapses (Xia et al., 1999). PICK1 may 
play an important role in the modulation of synaptic transmission by regulating the 
synaptic targeting of AMPA receptors (Xia et al., 1999). 
 
1.5.10. Docking Protein -7 (Dok-7) 
Dok-7 is a cytoplasmic protein composed of a pleckstrin-homology (PH) and PTB 
domains in the N-terminal portion and Src homology 2 (SH2) domain target motifs in the 
C-terminal region (Carpino et al., 1997; Yamanashi and Baltimore, 1997; Crowder et al., 
2004). Dok-7 binds to MuSK through the PTB domain in a manner dependent on the 
tyrosine phosphorylation of its target motif in MuSK (Okada et al., 2006). However PH 
domain, PTB domain and C-terminal all are required for the activation of MuSK in fully 
differentiated myotubes by Dok-7 (Okada et al., 2006). Dok-7 is essential for the 
formation of nerve- and agrin independent and dependent clusters (Okada et al., 2006). 
 
1.5.11. Protein kinase CK2 
CK2 is a highly conserved, ubiquitously expressed serine/threonine kinase present in all 
eukaryotes (Meggio and Pinna, 2003; Olsten and Litchfield, 2004). It is involved in many 
biological processes, such as proliferation, apoptosis, differentiation and tumorigenesis. 
The CK2 holoenzyme consists of a tetramer of two catalytic (α/α’) and two regulatory (β) 
subunits (Meggio and Pinna, 2003). CK2 interacts and colocalizes with MuSK at 
postsynaptic specializations. CK2 mediate phosphorylation of serine residues within the 
kinase insert (KI) of MuSK which is important for the maintenance of AChR clusters. 
Inhibition or knockdown of CK2, or exchange of phosphorylatable serines by alanines 
within the KI of MuSK, impairs acetylcholine receptor (AChR) clustering, whereas their 
substitution by residues that imitate constitutive phosphorylation led to aggregation of 
AChRs even in the presence of CK2 inhibitors. Moreover muscle-specific CK2β 
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knockout mice develop a myasthenic phenotype most likely due to impaired muscle 
endplate stability (Cheusova et al., 2006). 
 
1.5.12. Src-class kinases (SFKs) 
Src family of protein tyrosine kinases are non-receptor tyrosine kinase. Src family 
kinases are composed of six distinct functional regions (i) the Src homology (SH) 4 
domain, (ii) the unique region, (iii) the SH3 domain, (iv) the SH2 domain, (v) the catalytic 
domain, and (vi) a short negative regulatory tail (Brown and Cooper, 1996). Srcclass 
kinases (Src and Fyn) interact with MuSK through its phosphotyrosine-SH2 domain and 
mediate the effects of agrin-activated MuSK to regulate clustering and anchoring of 
AChRs in skeletal muscle (for detail see. 1.4.1. (Mohamed et al., 2001). 
 
1.5.13. Putative ariadne-like E3 ubiquitin ligase (PAUL) 
E3 ubiquitin ligase together with ubiquitin activating enzyme E1 and ubiquitin 
conjugating enzyme E2 covalently attaches ubiquitin to a lysine residue on a target 
protein. The E3 ubiquitin ligase is typically involved in polyubiquitination which marks 
proteins for degradation by the proteasome (Sun, 2006). Putative ariadne-like E3 
ubiquitin ligase (PAUL) was isolated by yeast-two-hybrid screens by virtue of its 
interaction with the cytoplasmic domain of MuSK. Paul is expressed at NMJs in muscle 
fibers but is not concentrated in AChR rich areas (Bromann et al., 2004). It has been 
recently shown that E3-dependent ubiquitination also serve as a regulatory mechanism 
for signaling and trafficking of several receptors (de Melker et al., 2001; Shenoy et al., 
2001). 
 
2.Aim of the study 
Studies published so far have put MuSK in the centre of the signalling process leading 
to neuromuscular development. However many aspect of this signalling process leading 
to and from MuSK are not fully worked out yet. To elucidate the signalling mechanism at 
NMJ we have undertaken a yeast-two-hybrid approach for the identification of proteins 
involved in signalling down-stream from MuSK. After the yeast-two-hybrid screen MuSK 
binding partners were further characterized and their biological role for NMJ 
development was assessed. One of the identified proteins interacting with the 
intracellular domain of MuSK was the carboxy-terminal part of ErbB2 interacting protein 
(Erbin). Epitope-mapping studies define the area of Erbin comprising amino acid 
residues between 1175 and 1229 in the carboxy terminus of the protein is necessary for 
its interaction with MuSK. This interaction was further characterized and its biological 
role for NMJ development and function, was assessed. 
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3. Material and methods 
 
3.1. Materials 
 
3.1.1. Reagents 
Basic solutions and reagents used have been purchased from Roche 
MolecularBiochemicals (Mannheim), Carl Roth (Karlsruhe), Promega (Mannheim), 
Sigma(Deisenhofen) or R&D Systems (Minneapolis, USA). Specific reagents used are 
listedbelow. 
 
Yeast-two-hybrid:  
5-bromo-4-chloro-3-indoxyl-beta-D galactopyranoside (X-Gal) Sigma 
β-Mercaptoethanol Sigma 
3-amino-1,2,4-triazole (3-AT) Sigma 
DMSO Roth 
Minimal SD Base media Clontech 
Amino acids for drop out (DO) supplement Sigma 
Yeast cells AH109, HF7c Clontech 
Carrier DNA Clontech 
YPD Medium Clontech 
Agar Bacto 
E. coli:  
BL21(Rosetta) Competent cells Novagen 
Escherichia coli XL1-Blue Competent cells Novagen 
Isopropyl-beta-D-thiogalactoside (IPTG) Sigma 
LB Broth Sigma
Molecular Biology and Biochemistry Standard Techniques:  
Agarose electrophoresis grade Gibco/BRL 
Ethidiumbromid  Gibco/BRL 
DEPC-treated water Roth 
Oligo-dT Invitrogen 
dNTPs Fermentas 
DNA polymerase 10xBuffer, Mg free Fermentas 
MgCl2 Fermentas 
MgCl2 Fermentas 
Ampicillin Sigma 
Luciferin Promega 
TRIzol Invitrogen 
Rotiphorese gel 40 (40% w/v acrylamide solution with 0.8% 
bisacrylamide in ratio 29:1) 
Roth 
TEMED Roth 
Dithiothreitol (DTT) Roth 
Protease inhibitor cocktail tablets-Complete and EDTA free  Applichem 
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3.1.2. Devices 
Horizontal gel electrophoresis apparatus (33 cm x 
42 cm) 
Gibco/BRL 
Horizontal gel electrophoresis apparatus OWI 
Electrophoresis Power Supply PS 304 Life Technologies 
Vertical mini-gel system Sigma 
Video documentation system for DNA Gels Biometra 
Gel-Blotting apparatus Multiphor II Pharmacia 
Film developer X-Omat 1000 Prozessor Kodak 
Gel dryer SE1160 Hoefer Scientific Instruments 
Phosphoimager Molecular Dynamics 
Water Bath GFL 
Centrifuge 5415D Eppendorf 
Centrifuge 5417R Eppendorf 
Centrifuge 5810R Eppendorf 
Centrifuge RC 5B Plus Sorvall 
Spectro Photometer Ultrospec 3000 Pharmacia 
Vortexer REAX2000 Heidolph 
Thermo mixer compact Eppendorf 
Luminescence reader Lumat LB9501 Berthold 
PCR-Thermocycler PTC-2000 Peletier Thermal 
Cycler 
MJ Research 
Phenylenmethylsulfonylfluorid (PMSF) Roche 
Lysozyme Roth 
Coomassie Brillant Blue Roche 
Protein A Sepharose CL4-B Amersham 
Ni-NTA agarose Qiagen 
Glutatione SepharoseTM 48 Amersham 
Ammonium Persulphate (APS) Roth 
Nitrocellulose membrane PROTRAN BA85 Schleicher & 
Schuell 
Bioscience 
P81 phosphocellulose paper Whatman 
NRG1 -β1/HRG1-β1 Extracellular Domain R&DSystems
Immunocytochemistry:  
Sodium azide Sigma 
Bovine Serum Albumin (BSA) Sigma 
Fetal Calf Serum (FCS) Serva 
Mowiol Invitrogen 
Proteinase K Roth 
Radiochemicals:  
γ-32P ATP Amersham 
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Lightcycler Roche 
Glass Teflon homogenizer Wheaton 
Homogenizer Kinematica AG (Dispersing and 
Mixing 
Technology) 
Ultrasonic Desintegrator Sonifier Branson 
Confocal laser-scanning microscope 
(LSM 5 Pascal) 
Leica 
Microscope MZ75 Leica 
Microscope DMIL Leica 
Inverted microscope (DMIRB) equipped with a 
cooled MicroMax CCD camera 
Leica/ Princeton Instruments 
Cryotom CM3050S Leica Microsystens, Nussloch 
Liquid Scintillation machine Wallac 1410 Pharmacia 
 
 
 
3.1.3. Oligonucleotides 
Oligonucleotides were synthesized by MWG-Biotech AG or Invitrogen. Their positions 
on the relative transcripts are indicated and correspond to the beginning of the coding 
sequence for forward (-bp) and the end of complementary sequence for reverse (bp-) 
primer. 
 
Name 
of the 
primer  
Sequence (5’-3’)  Restriction 
site  
Acc.No. Position 
(bp)  
Agrin-1  GTGGCGGCCGCAGCTGGAGATGCAGA 
GGCCA  
Not I  M94271.1  -5275  
Agrin-2  CGAAGATCTCTATTTGGCTGAGCAGTG Bgl II  M94271.1  5869-  
MUSK-
10  
CGGAATTCAGCGGGACTGAGAAACTT  EcoR I  NM_010944 
.2  
-52  
 C     
MUSK-
19  
CGCGGATCCTTAGCAGCAGTAGAT  BamH I  NM_010944 
.2  
297-  
 GCCATC     
MUSK-
20  
CGCGGATCCTTACGGCAGAACTGC  BamH I  NM_010944 
.2  
424-  
 CTTCAA     
MUSK-
21  
ACGCGTCGACTTAGGAGTACGCAG  Sal I  NM_010944 
.2  
1476-  
 GCGAGAC     
MuSK-
22  
CCGGAATTCGAGTCGACCGCGGTG  EcoR I  NM_010944 
.2  
- 1585  
 ACC     
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MuSK-
23  
CGCGGATCCTTACAGGCTGAGCAACTT BamH I  NM_010944 
.2  
1701-  
 AGG     
MuSK-
38  
GGAATTCTATTGCTGCCGAAGGAGGA  EcoR I  NM_010944.2  1552-  
 AA     
MuSK-
61  
ACGCGTCGACTTACTTGGGATTCAGAA Sal I  RNU34985  -1809  
 GGA     
MuSK-
62  
ACGCGTCGACTTAGCGCTGCAGGATCC Sal I  RNU34985  -2164  
 GGT     
MuSK-
63  
ACGCGTCGACTTACAGGTCACTGTGGC Sal I  RNU34985  -2688  
 TGA     
MuSK-
64  ACGCGTCGACTTAGACGCCTACCGTTC Sal I  RNU34985  -2724  
 CCA     
 
Table 3.1: Oligonucleotides, which were used for the generation of MuSK bait plasmids 
for a yeast-two-hybrid screening and mapping experiments. 
 
 
Name of 
the 
primer  
Sequence (5’-3’)  Restriction 
site  
Acc.No.  Position 
(bp)  
Erbin-11  CGGAATTCCGTGTCCTCCACAGCCT EcoR I  NM_018695.2  -3238  
 CT     
Erbin-12  CGGAATTCCGTACTTCGACATATTG EcoR I  NM_018695.2  -3598  
 AA     
Erbin-13  CGGAATTCCCCTCCATATACACAG  EcoR I  NM_018695.2  -3781  
 CCC     
Erbin-14  CCGCTCGAGTTATGAGGAAACTTC  Xho I  NM_018695.2  4116- 
 TCG     
Erbin-16  CCGCTCGAGTTACGAGCACTCTGA  Xho I  NM_018695.2  3437- 
 GGTCTTG     
Erbin-17  CCGCTCGAGTTATTCAATATGTCGA Xho I  NM_018695.2  3613- 
 AGTAC     
 
Table 3.2: Oligonucleotides used for subcloning of Erbin epitopes into yeast-two-hybrid 
prey vectors. 
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Table.3.3: Oligonucleotides used for subcloning of CMV-driven plasmids. 
Primer  Sequence (5’-3’)  Restr. 
 site  
Acc.No. Position 
(bp)  
Erbin-2  ATAGGTACCGTGTCCTCCACAGCCTCT  Kpn I  NM_018695.2  -3238  
Erbin-3  ATAGGTACCGTACTTCGACATATTGAA  Kpn I  NM_018695.2  -3598  
Erbin-4  ATAGGTACCCCTCCATATACACAGCCC  Kpn I  NM_018695.2  -3781  
Erbin-5  ATAAAGCTTTTATGAGGAAACTTCTCG Hind III NM_018695.2  4116- 
Erbin-6  ATAGGTACCCCTCAGCTCCTTCCTAGA  Kpn I  NM_018695.2  -3019  
Erbin-10  CCCAAGCTTTTAAGAGGCTGTGGAGGA  Hind III NM_018695.2  3255- 
 CAC     
Erbin-15  AACTGCAGGCTTCACCATGACTACAAA  Pst I  NM_018695.2  -1  
 AC     
Erbin-26  CCCAAGCTTGCCATGTCGCTGTCT  Hind III NM_021563.2  -37  
 ACGAGG     
Erbin-27  CCGCTCGAGTTAAAAGTCCTGGAGGTT  Xho I  NM_021563.2  773- 
 TTCACA     
Erbin-28  CCCAAGCTTAGTGCATTTAAAAATGAC  Hind III NM_021563.2  -314  
 TACAAAACG     
Erbin-29  ACGCGTCGACTGGCTCAATTAAGAAAC  Sal I  NM_021563.2  -275  
 ATCAGG     
Erbin-30  CGCGGATCCTTTGGGCTGATTAATCGA  BamH I NM_021563.2  2193- 
 GG     
Erbin-31  AGCAGCATGAAGATCAGCAAG   NM_021563.2  -1882  
Erbin-32  ATAGCGGCCGCCCCTCTAACCACAAGG  Not I  NM_021563.2  4615- 
 TCCA     
Erbin-45  CCGCTCGAGCATGACTACAAAACGAAG  Xho I  NM_018695.2  -1  
 TTTG     
Erbin-46  CCTAGGATTTGGTCTTTTTGAAGGAC Avr II  NM_018695.2  3522- 
Erbin-47  CCTAGGCCTTTGAGTAATGGAC  Avr II  NM_018695.2  -3636  
Erbin-48  CTAGCTAGCTTATGAGGAAACTTCT  Nhe I  NM_018695.2  4118- 
 CGTAC     
Erbin-62  CTAGGGCCCTTATGAGGAAACTTC 
TCGTAC  
Apa I  NM_018695.2  4117- 
GPI-3  CGGAATTCCGCTTTGACTCCAG  EcoRI  NM_005898.4  -1028  
GPI-4  CCGCTCGAGTGGATTGGAATGG  Xho  NM_005898.4  1546- 
NEDD-6  CCGCTCGAGTCAGAACGTTGCCAT  Xho I  NM_006403.2  2503- 
 CTC     
NEDD GGGAATTCGTCAAACCAGCCATGA  EcoR I  NM_006403.2  - 1499  
 C     
Phosphat
ase -3 
CGGAATTCCG TGTTCACCAAGG  EcoR I  BC002657.2  -13  
CK1α1-1  ATAGGATCCCATGGCGAGCAGCAG  BamH I NM_146087.1  -1 
 CGGCTC     
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Name 
of the 
primer  
Sequence (5’-3’)  Restriction 
site  
Acc.No.  Position 
(bp)  
MuSK-
39  
GGAATTCGTATTGCTGCCGAAGGAGG  EcoR I  NM_010944  1552- 
 AAA     
MuSK-
40  
CCGCTCGAGTTACTTAGGATTCAGAAG Xho I  NM_010944  -1698  
 GAG     
MuSK-
41  
CCGCTCGAGTTAGCGCTGCAGGATCCT Xho I  NM_010944  -2580  
 GTG     
MuSK-
42  
CCGCTCGAGTTACAGGTCACTGTGGCT Xho I  NM_010944  -2055  
 GAG     
MuSK-
44  CCGCTCGAGTTAGACACCCACCGTTCC Xho I  MMU37709  -2755  
 CTC     
 
Table.3.4: Oligonucleotides used for the PCR amplification of different MuSK 
intracellular domains for the generation of CMV - expression plasmids. 
 
 
Erbin-
9  
CGGAATTCTACCTCCATATACACAGCC  EcoRI NM_018695.2  -3781 
 C     
Erbin-
10  
CCCAAGCTTTTAAGAGGCTGTGGAGGA Hind 
III  
NM_018695.2  3255-
 CAC     
Erbin-
16  
CCGCTCGAGTTACGAGCACTCTGAGGT Xho I NM_018695.2  3437-
 CTTG     
Erbin-
17  
CCGCTCGAGTTATTCAATATGTCGAAG  Xho I NM_018695.2  3613-
 TAC     
Erbin-
18  
CCGCTCGAGTTAGGGCTGTGTATATGG Xho I NM_018695.2  3798-
 AGG     
Erbin-
19  
CGGAATTCGGCACGAGCTCGTGCCGC EcoR 
I  
NM_018695.2  -3017 
     
Erbin-
33  
CCGCTCGAGTTATGTCGCTGGATTGTA  Xho I NM_018695.2  3230-
 CTTCG     
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Erbin-
34  
CGGAATTCCAGCAAGACATGGGGAAAT EcoR 
I  
NM_018695.2  -3148 
 GT     
Erbin-
35  
CCGCTCGAGTTAATTTCATTAATAGAG  Xho I NM_018695.2  3455-
 GGTCGAGCA     
Erbin-
36  
CGGAATTCTGATGCCAGGATCACAGAG EcoR 
I  
NM_018695.2  -3356 
 A     
Erbin-
37  
CCGCTCGAGTTATGCATTTGGTCTTTTT Xho I NM_018695.2  3525-
 GAAGG     
Erbin-
38  
CGGAATTCGTGCTCGACCCTCTATTAAT EcoR 
I  
NM_018695.2  -3431 
 GAAAT     
Erbin-
39  
CCGCTCGAGTTAATAATTTGCCTGAGG  Xho I NM_018695.2  3687-
 CCTGA     
Erbin-
40  
CGGAATTCTTCGACATATTGAAGCCAA  EcoR 
I  
NM_018695.2  -3601 
 AAA     
Erbin-
41  
CCGCTCGAGTTACTTGTTTTGCCAGTTC Xho I NM_018695.2  3838-
 ATGG     
Erbin-
42  
 EcoR 
I  
NM_018695.2  -3763 
 CGGAATTCTGAAAGTGGCCCACCAG     
Y2H-
1  
CCCCCGGGCTGCAGGAATTCTGGCACG 
AG  
Eco R 
I  
pGAD.GH  - 839 
Y2H-
2  
AATGGGTACCGGGCCCCCCCTCGAGGT 
G  
Xho I pGAD.GH  908- 
 
Table 3.5: Oligonucleotides used for the generation of pGEXKG constructs, expressing 
the GSTfusions of Erbin epitopes. 
 
 
Name 
of the 
primer  
Sequence (5’-3’)  Acc.No. Position 
(bp)  
Erbin-
22  CCAGGCTCTACAAGGCGGGCTCAGATTGCTGAAGG NM_018695.2  -3271  
 AGATTATTTATCATACAGAG    
Erbin-
23  CTCTGTATGATAAATAATCTCCTTCAGCAATCTGAG  NM_018695.2  3325-  
 CCCGCCTTGTAGAGCCTGG    
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Erbin-
24  CCACTCAGCGGGAAGAACTCCTGCAATGATGGCAG NM_018695.2  -3330  
 GATCACAGAGACCCCTTTCTGC    
Erbin-
25  GCAGAAAGGGGTCTCTGTGATCCTGCCATCATTGC NM_018695.2  3386-  
 AGGAGTTCTTCCCGCTGAGTGG    
Erbin-
43  CCAGAGAGAACTATGTCAGTTAGTGATTTCAATGC  NM_018695.2  -3457  
 TTCACGGACTAGTCCTTCAAAAAGACCAAATGC    
Erbin-
44  GCATTTGGTCTTTTTGAAGGACTAGTCCGTGAAGCA NM_018695.2  3524-  
 TTGAAATCACTAACTGACATAGTTCTCTCTGG    
 
Table.3.6: Oligonucleotides used for the generation of Erbin point mutants. Sites of 
mutation are underlined. 
 
Name of the 
primer  
Sequence (5’-3’)  Restriction 
site  
Acc.No.  Position 
(bp)  
MuSK-83  CGGAATTCTACTATGGAATGGCCC  EcoR I  NM_010944.2  - 2403  
 ACGA     
MuSK-84  CCGCTCGAGTGGATACTGCAGAAG 
CTGGGTCT  
Xho I  NM_01094.2  2555- 
MuSK-86  CGCGGATCCTGCTGCCGAAGGAGG 
AAAGA  
BamH I  NM_010944.2  - 1546  
MuSK-87  CGGAATTCATACTCCAGGCTGAGC  EcoR I  NM_010944.2  1707- 
 AACT     
 
Table 3.7: Oligonucleotides used for the generation of pET28a constructs, expressing 
the Hisfusions of MuSK epitopes. 
 
 
 
Name of  the  Sequence (5’-3’)  Acc.No.  Position 
(bp)  
Product 
primer       size 
(bp)  
AChRα-1   ACGCTGAGCATCTCTGTCTT NM_007389  810-  448  
AChRα-2   TTGGACTCCTGGTCTGACTT NM_007389  -1258  
MuSK-24  GCCTTGGTTGAAGAAGTAGC  NM_010944  115-  353  
MuSK-25  CTTGATCCAGGACACAGATG  NM_010944  -488  
Erbin   CAGGAGAGTGTTGCCAAGAT  NM_021563.2  -3629  210  
Erbin   CATGGCCTTGTCTAG GAG AA  NM_021563.2  3838- 
mbact-
111 
 TGGAATCCTGTGGCATCCATGA NM_007393  885-  350  
  AA     
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mbact-
112 
 TAAAACGCAGCTCAGTAACAGT NM_007393  -1235  
  CCG     
MuSK   GCT CTT CTC ACC ATC GCT AC  NM_010944  1519  
 
MuSK   GGA CAT ACT TCG GAG GAA  NM_010944  2010   
  CT     
β-actin   TGG AAT CCT GTG GCA TCC  NM_007393  Pos. 806  
 
  ATG AAA     
β-actin   TAA AAC GCA GCT CAG TAA  NM_007393  Pos. 1154  
 
  CAG TCC G     
MuSK in rats  AGA GGA TGC CAC TCC TTC TG  NM_031061.1  
Pos. 
1661  
 
MuSK in rats  CGG AGG AAC TCA TTG AGG  NM_031061.1  Pos. 2000  
 
 TC     
β-actin rats  TCT ACA ATG AGC TGC GTG TG  
NM_031144.2  Pos. 
269  
 
β-actin rats  CCA TCT CTT GCT CGA AGT CT  
NM_031144.2  Pos. 
682  
 
Table. 3.8: Oligonucleotides pairs used for quantitative PCR reactions. Size of resulting 
PCR product is given in bp. 
 
Name 
of the 
primer  
Sequence (5’-3’)  Restriction 
site  
Acc.No.  Position 
(bp)  
MuSK-
52  
ATAGGATCCACCGTGGTGCTTCC 
TAAGCTCAGAG  
BamH I  Mouse 
Genomic 
locus  
12865-  
MuSK-
53  
ATAGAATTCGTTCTAAGTCTGCA 
GGCACAAGACCC  
EcoR I  Mouse 
Genomic 
locus  
-12865  
MuSK-
54  
ATACGGACCGGTAGAACCGCTCC 
AATGACCTTTGTG  
Rsr II  Mouse 
Genomic 
locus  
14675-  
MuSK-
60  
ATAGAGCTCGGATTTAGTAGTCA 
AATGAAGCAG  
Sac I  Mouse 
Genomic 
locus  
- 10246 
MuSK-
100  CTGGTTCCGTGTGTATGTGTG  
 Mouse 
Genomic  
 
   locus  -9509  
 
Table 3.9: Oligonucleotides used for the generation of MuSK conditional Knockout mice. 
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3.1.4. siRNAs 
For silencing of Erbin, pSUPERneoGFP (Oligoengine) based shRNAs were 
used.Targeting sequences were designed using Sfold program (Ding et al., 2004). 
Targeting oligonucleotides were synthesized by Invitrogen. 
 
 
Name  
Target  Inhibition 
efficiency  
Primers  Sequence of primers  Acc.No.  Pos. 
pSuper Neo  Erbin  53%  Erbin- GATCCCCACCATG  NM_021563.2 -36  
EGFP (E979)-   siRNA-1  TCGCTGTCTACGAT    
Erbin-
siR 
NA-    TCAAGAGATCGTA    
36      GACAGCGACATGG    
     TTTTTTGGAAA    
AGCTTTTCCAAAA   
    siRNA-2  AACCATGTCGCTG    
     TCTACGATCTCTTG    
     AATCGTAGACAGC    
     GACATGGTGGG    
pSuper  Neo  Erbin  76%  Erbin- GATCCCCGAAGAGCT  NM_021563.2  -175 
EGFP  (E979)-   siRNA-3  TCCAAAGCAACTTCA    
Erbin-
siR 
NA-175     AGAGAGTTGCTTTGG    
     AAGCTCTTCTTTTTG    
     GAAA    
AGCTTTTCCAAAAAG  
    siRNA-4  AAGAGCTTCCAAAG    
     CAACTCTCTTGAAGT    
     TGCTTTGGAAGCTCT    
     TCGGG    
        
 
Table.3.10: Erbin siRNA 
 
3.1.5. Enzymes 
 
Restriction enzymes  New England BioLabs, Gibco/BRL, 
Roche, Fermentas  
RNase A  Roth  
M MulV Reverse Transcriptase  New England Biolabs  
APex TM Heat-Labile alkaline 
phosphatase  
Epicenter  
Taq DNA polymerase  Fermentas  
T4 DNA ligase  Roche  
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3.1.6. Kits and Columns 
 
Plasmid DNA Purification Kit 
(Nucleobond AX)  
Macherey-
Nagel  
DNA Purification Kit (Nucleospin 
Extract)  
Macherey-
Nagel  
High Pure Plasmid Isolation Kit  Roche  
Quikchange XL Site-directed 
Mutagenesis Kit  
Stratagene  
Lightcycler–FastStart DNA Master 
SYBR Green  
Roche  
Kit   
Centricon Plus-20 Centrifugal Filter 
Device  
Amicon 
bioseparations  
 
3.1.7. Antibodies 
 
Antigen (species)  Use and Dilution  Company/Suppliers  
T7  WB 1:10000  Novagen  
(mouse monoclonal)  IP 1:1000   
Myc  WB 1:10000  Cell Signaling  
(mouse monoclonal)  IP 1:1000   
α−ΗΑ (mouse 
monoclonal)  
WB 1:10000 IP 1:1000  Cell Signaling  
α-MuSK Rb194T (rabbit 
polyclonal)  
WB 1:1000 IHC 1:1000 
IP 1:10  
Dr. Markus Ruegg, 
Biocenter, Basel, 
Switzerland  
α-GFAP  IHC 1:500  Chemicon, Temecula, CA  
α-glutamine synthetase 
mouse  
IHC 1:500  BD Transduction 
Laboratories  
α-choline 
acetyltransferase  
IHC 1:1,000  Chemicon  
α-Thy1 mouse  IHC 1:500  BD Transduction Laboratories  
α-agrin (AGR-540) 
mouse  
IHC 1:500  Stressgen  
α-MuSK 20kD  WB 1:3000  self-generated  
(rabbit polyclonal)    
  
B. Secondary antibodies 
 
Antigen (species)  Use and 
Dilution  
Company/ 
Suppliers  
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Goat anti-mouse 
conjugated  
IgG HRP- WB 1:10,000  Amersham 
Pharmacia 
Biotech  
Protein A HRP-conjugated  WB 1:3,000  
Amersham 
Pharmacia 
Biotech  
Cy2-cojugated goat anti-mouse IgG  IHC 1:100  Dianova  
Cy2-cojugated goat anti-rabbit IgG  IHC 1:100  Dianova  
Cy3-cojugated goat anti-mouse IgG  IHC 1:200  Dianova  
Cy2-cojugated goat anti-mouse IgG  IHC 1:200  Dianova  
Alexafluorescence)anti-
rabbit IgG  
488 (green 
conjugated 
goat  
IHC 1:500  Molecular 
Probes  
 
3.1.8. Frequently used solutions 
 
Solution name  Composition  
10xDNA loading buffer  50% Glycerin, 0.1% Xylene cyanol 
FF, 0.1%  
 Bromophenol blue  
1xTBE buffer  88 mM Tris, 88 mM Boracid, 2 mM 
EDTA pH  
 8.3  
3x Lammli buffer  187 mM Tris, 6% SDS, 30% 
Glycerin, 0.02%  
 Bromophenol blue, 15% β-
Mercaptoethanol  
1xPBS  140 mM NaCl, 2.7 mM KCl, 8.1 mM 
Na2HPO4 x  
 2 H2O, 1.5 mM KH2PO4  
PBST  PBS, 0.1% Tween-20  
Mowiol  6 ml water was added to 6.0 g 
Glycerol and 2.4 g  
 Mowiol and left for 2 h at RT. 
Afterwards, 12 ml  
 0.2 M Tris pH 8.5 was added and 
the solution was  
 rotated for 24 h at 53°C, followed by  
 centrifugation at 3220 rcf and 
aliquoting. Mowiol  
 solution was stored at -20°C for up 
to 12 months.  
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4% PFA  20 g Paraformaldehyde (PFA) was 
dissolved in  
 300 ml water (65ºC). After pH was 
adjusted to 7.4  
 water was added up to 500 ml, and 
the solution was sterile filtered, 
aliquoted and stored at -20ºC.  
Tail lysis buffer  50 mM Tris-HCl pH 8.0, 100 mM 
EDTA, 0.1 M  
 NaCl, 1% SDS  
  
 
3.1.9. Cell culture 
 
Human embryonic kidney 293 cells 
(HEK293)  
American Type Culture Collection  
Cos7  American Type Culture Collection  
C2C12  Gift from Dr. Hans-Rudolf Brenner  
MuSK-deficient myoblasts (MuSK-/-) 
C3.16  
Gift from Drs. Ruth Herbst and 
Steven Burden  
HEK293 cells expressing 
continuously secretable  
Gift from Dr. Stefan Kröger  
active (4.8.) or inactive (0.0) agrin   
Dulbecco’s MEM (DMEM) with 
GlutamaxTM-1  
Gibco/BRL  
with Sodium Pyruvate and 4500 
mg/L Glucose  
 
Fetal Calf Serum (FCS)  Invitrogen  
Heat-inactivated Horse Serum (HS)  Invitrogen  
Chick Embryo Extract (CEE)  SLI  
Mouse recombinant interferon-γ  Sigma  
Matrigel  Becton Dickinson  
Apigenin  Sigma, HCLP grade  
2-Dimethylamino-4,5,6,7-tetrabromo-
1H- 
Gift from Drs. Flavio Meggio and 
Lorenzo A.  
benzimidazole (DMAT)  Pinna  
Rhodamine-α-bungarotoxin (Rh-
α-BTX)  or 
Molecular Probes, Eugene  
Alexa-α-bungarotoxin (Alexa-α-
BTX)  
  
SuperFect   Qiagen  
LipofectamineTM 2000   Invitrogen  
DEAE-Dextran  Pharmacia, Sigma  
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3.2. Methods 
Standard methods were performed according to: Sambrook, J., Russell D.W., Molecular 
Cloning: A Laboratory Manual, 3rd edition (Volume 1-2-3), Cold Spring Harbor 
Laboratory Press, 2001. 
 
3.2.1. Molecular Biology Methods 
 
3.2.1.1. Isolation of plasmid DNA 
Up to 10 μg of plasmid DNA was isolated using the following protocol. Bacterial cells 
were pelleted by centrifugation. Cell pellet was resuspended in 100 μl of buffer S1 (50 
mM Tris, 10 mM EDTA, 100 μg/ml RNase A pH 8.0). Then 200 μl of S2 buffer (200 mM 
NaOH, 1% SDS) was added and mixed gently by inverting to avoid shearing of the 
genomic DNA. After 5 min of incubation 150 μl of S3 buffer (2.8 M KAc pH 5.1) was 
added and mixed gently. The mixture was put on ice for 5 min. After 5 min of incubation 
mixture was centrifuged at 4°C (20000 rcf for 10min). To precipitate the plasmid DNA, 1 
ml of absolute Ethanol was added to the supernatant, mixed and centrifuged at 4°C 
(20000 rcf for 10 min). The pellet was centrifuged once more with 300 μl of 70% Ethanol 
at 4ºC (20000 rcf for 5 min), air dried, and resuspended in 50 μl water. 
Larger amounts of plasmid DNA (20-2500 μg) was isolated with the use of Macherey- 
Nagel Plasmid DNA Purification Kit (Nucleobond AX) according the manufactures 
protocol, which is based on a modified alkaline lyses procedure followed by binding of 
plasmid DNA to an anion-exchange resin under appropriate low-salt and pH conditions. 
RNA, proteins and low molecular weight impurities were removed by a medium-salt 
wash; DNA is eluted in a high salt buffer and then concentrated and desalted by 
isopropanol precipitation. 
 
3.2.1.2. Determination of DNA/RNA concentration 
The concentration of DNA/RNA in solution was determined in a spectrophotometer, 
measuring the absorption of the solution at 260 nm and using the following formulas: 
1A260 =50 μg double stranded DNA 
1A260 =33 μg single stranded DNA 
1A260 =40 μg RNA 
 
3.2.1.3. Electrophoretic separation of DNA fragments in agarose gel 
DNA was loaded on 0.7-2 % agarose gels prepared in 1xTBE buffer with 0.5 μg/ml 
ethidium bromide. The electrophoresis was performed for ~1 h at 120 V (Horizontal gel 
electrophoresis apparatus -Gibco/BRL). The DNA fragments were visualized under UV 
light. 
 
3.2.1.4. PCR amplification of DNA 
The Polymerase-Chain-Reaction (PCR) was performed according to the method of Saiki 
(Saiki et al., 1986). A standard PCR reaction to amplify DNA from plasmid template 
contained about 50 ng plasmid DNA, forward and reverse primers (10 pmol each), 200 
μM dNTPs, 1xTaq-polymerase buffer + (NH4)2SO4, 2 mM MgCl2 and 1U Taq DNA 
polymerase (Fermentas), in a total volume of 50 μl. 
41 
 
The amplification was carried out in a PCR-Thermocycler PTC-2000 Peletier Thermal 
Cycler (MJ Research). The amplification conditions were as follows: 
(1) Initial denaturation for 2 min at 94°C. 
(2) 25-30 cycles of 10-30 sec at 94°C, 10-30 sec at the annealing temperature of the 
primer pair and extension of 1 min/kbp at 72°C. 
(3) Incubation for 5 min at the extension temperature to allow for the complete 
amplification of all products. 
The annealing temperature, the time of denaturation, annealing and the extension were 
optimized for each experiment. The PCR products were then analyzed in an agarose gel 
by separation according to their size. 
 
3.2.1.5. Cloning techniques 
The DNA fragment to be subcloned was amplified by PCR (see 3.2.1.4.) using specific 
primers containing unique restriction sites, analyzed on an agarose gel (see 3.2.1.3.) 
and purified either by using DNA Purification Kit - Nucleospin Extract (Macherey 
Machinery) or by the Tombstone procedure. To carry out the Tombstone procedure the 
gel area directly above (towards the cathode) and under (towards to anode) the band of 
the PCR product was cut and pieces of DE81 cellulose paper were inserted into the 
nicks. 
During further migration of the DNA the desired PCR product was transferred and bound 
to the lower DE81 paper, while the upper DE81 paper prevented contamination of the 
PCR product with other DNA fragments. The DE81 paper with the PCR product was 
removed from the gel and placed into a 0.5 ml PCR tube with a hole at the bottom and 
inserted into the 1.5 ml Eppendorf tube. Residual TBE buffer was removed from the 
DE81 paper by centrifugation (16000 rcf for 30 sec.). DNA of the PCR fragment was 
eluted three times from the DE81 paper with high salt Tombstone buffer (1 M LiCl, 20% 
Ethanol, 10 mM Tris pH 7.5, 1 mM EDTA) and precipitated with three volumes of 
absolute Ethanol, washed with 80% Ethanol, air dried and dissolved in 20 μl of water. 
The purified PCR product and the subcloning vector were digested in a total volume of 
20 μl comprising of about 1 U of restriction enzyme per 1 μg of DNA, 2 μl of 10x 
corresponding restriction buffer and sterile water. Digestion mixture was incubated at 37 
ºC for 1 hour. When the vector ends were blunt or compatible with each other, the vector 
was dephosphorylated prior to ligation to prevent self-ligation. To remove 5’ phosphates 
from the vector, 1 U of APex TM Heat-Labile alkaline phosphatase (Epicenter) was 
added 
directly to the digestion reaction. The reaction was incubated for 20 min at 37°C. 
Phosphatase was heat inactivated at 70°C for 5 min. After enzymatic digestion or 
dephosphorylation the vector or PCR product were purified by agarose gel 
electrophoresis. Before ligation the concentrations of PCR-fragment and vector were 
roughly estimated on an agarose gel. A typical ligation reaction contained vector and 
insert at a molar ratio of about 1:2 (600 ng total DNA), 1x ligase buffer (New England 
BioLabs), and 1 U of T4 DNA Ligase (New Englang BioLabs) in a volume of 10 μl. The 
incubation was carried out at RT for 5 h or at 16°C for 12-16 h. After that, 1 μl of the 
ligation reaction was transformed in Escherichia coli competent cells. 
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3.2.1.6. Plasmid constructs 
Plasmid constructs generated according to the basic cloning techniques (3.2.1.5.) are 
listed in the Table 3.11. For primers sequences and Acc.No. position: see 3.1.3. 
 
Plasmid name  Primers used for 
subcloning  
Restriction 
digestion sites 
used for 
subcloning  
Template used 
for 
PCR/subcloning 
pCMX.PL1-T7-
CK2β 
CK2β-3/CK2β-4  Hind III/Xho I  pGADGH-
CK2β-full length 
(fished by Y2H)  
pCDNA3-6HA-
CK1α1  
CK1α1-1/CK1α1-
2  
BamH I/EcoR I  Brain 1st strand 
cDNA  
pCDNA3-6HA-
CK1δ 
CK1δ -1/CK1δ -1 BamH I/EcoR I  Brain 1st strand 
cDNA  
pCDNA3-6HA-
CK1ε 
CK1ε-3/CK1ε-4  EcoR I/Xho I  Brain 1st strand 
cDNA  
pCDNA3-6HA-
CK1γ1  
CK1γ1-1/CK1γ1-
2  
BamH I/EcoR I  Brain 1st strand 
cDNA  
pCDNA3-6HA-
CK1γ3  
CK1γ3-1/CK1γ3-
2  
BamH I/EcoR I  Brain 1st strand 
cDNA  
pCDNA3-6HA- 
Fzd3  
Fzd3-1/Fzd3-2  BamH I/EcoR I  Brain 1st strand 
cDNA  
pCMX.PL1-T7- 
Fzd4  
Fzd4-1/Fzd4-2  EcoR I/Pst I  Brain 1st strand 
cDNA  
pCDNA3-6HA- 
LRP6  
LRP6-1/LRP6-2  BamH I/Xho I  Brain 1st strand 
cDNA  
pBSK+MuSK Long 
Left Arm  
MuSK-60/MuSK-
52  
BamH I/Sac I  ES mouse 
Genomic DNA  
pBSK+ MuSK Long 
Left Arm-LoxP  
LoxP-BglII-SacI-
I/ LoxP-BglII-
SacI-II  
Avr II   
pBSK+ MuSK Long 
Left Arm-LoxP-Neo  
 Hpa I/Sma I  pJNI-Neo vector 
pBSK+ MuSK Long 
Left Arm-LoxP-Neo-
Right Arm.  
MuSK-53/MuSK-
54  
EcoR I/Rsr II  ES mouse 
Genomic DNA  
pBSK+ MuSK Long 
Left Arm-LoxP-Neo-
Right Arm-DT  
 Rsr II  pKO-DT  
pCDNA3-6HA-
ErbinY2H  
 BamH I/Xho I  pGAD-GH-
Erbin-
Y2H(fished by 
Y2H)  
pCMV5-T7b-  Hind III/Not 1  pCDNA3-
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MuSk2xwt  MuSK2xwt  
pCMV5-c-myc-tag-
Erbin- deletion 
mutants  
Erbin -2, Erbin -
3, Erbin -4, Erbin 
-5/Erbin -6  
Kpn I/Hind III  pGAD-GH-
Erbin-
Y2H(fished by 
Y2H)  
pCMV5-T7a-
Erbin38  
 BamH I/Hind III  pGEX.KG-
Erbin38  
pCMV5-T7a-Erbin  Erbin-29/Erbin 
30 Erbin-
31/Erbin-32  
Sal I/BamH I Hpa 
I/Not I  
C2C12 1st 
strand cDNA  
pCMV5-T7a-
MuSk2xKD-myc 
 Hind III/Not I  pCDNA3-
MuSK2xKD  
pCMX.PL1-CKII  CK2β-3/CK2β-4  Hind III/Xho I  pGADGH-
CK2β-full length 
(fished by Y2H)  
pCMX.PL1-Luc-
Erbin-human  
Erbin-10/Erbin-
15  
Pst I  pRK5-myc-
Erbin  
pCMX.PL1-Luc-
Erbin-mouse  
Erbin-26/Erbin-
27  
Hind III/Xho I  C2C12 1st 
strand cDNA  
pCMX.PL1-T7-
ERBIN-Y2H 
 EcoR I  pGAD-GH-
Erbin-Y2H 
(fished by Y2H)  
pCMX.PL1-T7-GPI-
4  
GPI-3/GPI-4  EcoR I /Xho I  pGAD.GH-GPI 
(fished by Y2H)  
pCMX.PL1-T7- Phosphatase-3/Y2H-3  EcoR I/Hind III  pGAD.GH- 
 
Table 3.11. Plasmid constructs. 
 
pcDNA-MuSK2xwt-myc and pcDNA-MuSK2xkd-myc constructs have been generated 
and kindly provided by the group of Prof. Hans-Rudolf Brenner. For their generation two 
intracellular domains of MuSK or its kinase defective mutant (aa 467-868; Acc.No. 
U34985) were linked together by five E/G (E-Glutamic Acid, G-Glycine) modules. The 
first intracellular MuSK domain was subcloned into Hind III/Nhe I of myc-tagged pcDNA3 
(Invitrogen). The second intracellular MuSK domain was joined by ligation into the Nhe I 
and EcoR I sites of the plasmid. 
For the generation of pSUPERneoGFP based siRNAs (3.1.4.) used for silencing of 
mouse Erbin a pair of oligonucleotides according to the following design was 
synthesized: 
         compatible with BglII 
5’ – GATCCCCC ( sense ) TTCAAGAGA (anti sense) TTTTTGGAAA – 3’ 
3’ – GGG (anti sense) AAGTTCTCT ( sense ) AAAAACCTTTTCGA – 5’ 
                                                       hairpin loop                                           compatible with HindIII 
Sense and anti sense specific sequences targeting the mRNA of corresponding genes 
were designed with the software Sfold (Ding et al., 2004). The oligos were hybridized 
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and subcloned into restriction digestion sites Hind III/Bgl II of pSUPERneoGFP(E979) 
(Oligoengine) destroying at the same time the Bgl II site. 
CMV expression plasmids pCMX.PL1, carrying the luciferase gene and Erbin’ cDNA as 
bicistronic message were constructed as follows. Luciferase gene was amplified by PCR 
from the plasmid pGL2-basic (using primers Luc-1: 5’- 
CGGGATCCATGGAAGACGCCAAAAAC-3’ and Luc-2: 5'- 
CGGGATCCTTACAATTTGGACTTTCC-3' and subcloned into BamH I site of 
pCMX.PL1 (then named pCMX.PL1-Luc). Erbin cDNA was amplified from 1st strand 
cDNA from C2C12 myotubes and ligated into the Hind III/Xho I of pCMX.PL1-Luc. 
 
3.2.1.7. Transformation of E. coli competent cells 
While XL1-blue cells were used for subcloning of plasmid vectors, BL21 cells were used 
for protein expression. 1-10 ng of plasmid DNA or an aliquot from a ligation reaction (1 
μl) were added to 50 μl of E. coli XL1-Blue or BL21 (Rosetta) electrocompetent cells 
(Novagen). The cell-DNA mixture was transferred into a prechilled electroporation 
cuvette (EquiBio). DNA was transformed into the bacteria cells by means of an electric 
impulse (1800 V, 7.5 ms). After electroporation the bacteria were shaken for 30 min at 
37°C in 200 μl of LB medium, then plated on LB plates containing antibiotic (100 μg/ml 
ampicillin or kanamicin) and incubated at 37°C for about 16 h, until colonies appeared. 
 
3.2.1.8. Site directed mutagenesis 
Substitutions of P (Proline) residues by A (Alanine) within the pRK5-myc-Erbin and 
pGEXKG-Erbin-Y2H and Y (Tyrosine) by A (Alanine) within the pGEXKG-Erbin-38 were 
introduced, using the Quikchange XL Site-directed Mutagenesis Kit (Stratagene). 
Primers for the site directed mutagenesis should fulfill the following criteria: have a 
length 25-50 bp, Tm>78°C and carry a mutation of nucleotide(s), which would lead to 
the exchange of the desired amino acid without a shift in the open reading frame of the 
targeted gene. A plasmid carrying the target gene serves as a template for the 
mutagenesis PCR. Usage of PfuTurbo DNA-Polymerase ensures high fidelity of the 
PCR reaction. Dpn I digestion results in the elimination of the methylated form of the 
template plasmid. Remaining unmethylated plasmid produced by PCR and carrying the 
mutated gene is subsequently transformed into E. coli competent cells. 
A 20 μl PCR reaction contains: 2 μl of 10x reaction buffer, 1.2 μl Quicksolution, 0.4 μl 
dNTP Mix, 125 ng of two primers and 10 ng of template plasmid. Combinations of the 
primers and templates used al well as the resulting mutations are indicated in the Table 
3.12. 
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Primer combination  Template  Mutation  Resulted plasmid  
Erbin22 and Erbin23  pGEX-KG-ERBIN 
1118  
P-1121 
→A  
pGEX-KG-ERBIN 
1110  
 PA + 1121 PA  P-1118 
→A P-
1100 →A  
PA + 1118 PA + 
1121 PA (3PA)  
Erbin 22 and Erbin 
23.  
pGEX-KG-ERBIN-
Y2H  
P-1100 
→A  
pGEX-KG-ERBIN 
1100  
   PA (1PA)  
Erbin24 and Erbin25  pGEX-KG-ERBIN-
Y2H  
P-1121 
→A  
pGEX-KG-ERBIN 
1118  
  P- 
1118→A  
PA + 1121 PA 
(2PA)  
Erbin43 and Erbin44  pGEX-KG-
ERBIN38  
Y-1164 
→A  
pGEX-KG-
ERBIN38-YA  
Erbin22 and Erbin23  pRK5-myc-ERBIN P-1100 
→A  
pRK5-myc-ERBIN 
1100  
   PA (1PA)  
Erbin24 and Erbin25  pRK5-myc-ERBIN P-
1118→A  
pRK5-myc-ERBIN 
1118  
  P-?→A  PA + 1121 PA (2PA )  
Erbin22 and Erbin23  pRK5-myc-ERBIN 
1118 PA + 1121 
PA  
P-1110 
→A P-
1118→A 
P-
1121→A  
pRK5-myc-ERBIN 
1110 PA + 1118 
PA + 1121 PA 
(3PA )  
 
Table 3.12: Combination of primers (see Table.3.6) and templates used for site directed 
mutagenesis of MuSK. 
 
Mutagenesis PCR for pRK5-myc-Erbin was carried out according to the program 
indicated in the Table 3.13. 
 
Step  Number of cycles  Temperature Time  
Denaturation 1  95°C  1 min  
Amplification  18  95°C 50 sec  
60°C 50 sec  
68°C 10 min  
Elongation  1  68°C  14 min  
 
 Table 3.13: The program of the site directed mutagenesis PCR for pRK5-myc-Erbin. 
46 
 
 
Mutagenesis PCR for pGEX-KG-ERBIN-Y2H was carried out according to the program 
indicated in the Table 3.14. 
 
Step  Number of cycles  Temperature Time  
Denaturation 1  95°C  1 min  
Amplification  18  95°C 50 sec  
60°C 50 sec  
68°C 7 min  
Elongation  1  68°C  10 min  
 
Table 3.14: The program of the site directed mutagenesis PCR for pGEX-KG-ERBIN-
Y2H. 
 
Mutagenesis PCR for pGEX-KG-ERBIN38 was carried out according to the program 
indicated in the Table 3.15. 
 
Step  Number of cycles  Temperature Time  
Denaturation 1  95°C  1 min  
Amplification  18  95°C 50 sec  
60°C 50 sec  
68°C 6 min  
Elongation 1  68°C  8 min  
 
 Table 3.15: The program of the site directed mutagenesis PCR for pGEX-KG-ERBIN38. 
 
The PCR product was digested with 1 μl Dpn I at 37°C for 1 h. XL1-Blue 
electrocompetent bacteria were transformed with 1 μl of digested PCR product. Plasmid 
DNA was isolated from bacterial clones and verified by sequencing. 
 
3.2.1.9. Total RNA isolation 
Total RNA was extracted from rat or mouse tissues, C2C12 myoblasts, C2C12 
myotubes treated with inactive 0.0 or active 4.8 isoforms of agrin using the TRIzol 
Reagent (Invitrogen). 1 ml of TRIzol reagent was used per 50-100 mg of tissue or per 10 
cm cell plate area. To follow developmentally regulated MuSK expression, rat eye tissue 
because of its larger size was used due to easier dissection compared with mice. Total 
RNA was extracted from eyes of rats at different stages (the term adult reflects rats 
aged from 2 to 4 month). 
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Tissues were homogenized using an automatic homogenizer (Kinematica); insoluble 
material was removed by centrifugation (12000 g for 10 min at 2-8°C). After 5 min at RT 
0.2 ml chloroform was added per 1 ml TRIzol Reagent, vortexed for 15 sec, incubated 
additional 3 min at RT and centrifuged (12000 g for 15 min at 2-8°C). The aqueous 
phase was transferred to a fresh tube and RNA was precipitated with 0.5 ml isopropanol 
per 1 ml TRIzol reagent for 10 min at RT. After centrifugation (12000 g for 15 min at 2-
8°C) the RNA pellet was washed with 75% Ethanol, briefly dried and dissolved in RNAse 
free water. RNA was aliquoted and stored at -80°C. 
 
3.2.1.10. Complementary DNA-synthesis (Reverse Transcription) 
The reverse transcription (RT) allows the transcription of RNA into complementary DNA 
(cDNA) that can be subsequently used as template for PCR. For cDNA-synthesis, 2 μg 
of total RNA was incubated in a total volume of 15.5 μl, including 1 μl of oligo-dT (0.5 
μg/μl) (Invitrogen) and DEPC water at 70°C for 10 min and then quickly chilled on ice to 
open secondary structures. The following mix: 2.5 μl of 10x First-Strand Buffer (New 
England BioLabs), 4 μl dNTP mix (10 mM) and 2 μl of DEPC water, was then added to 
each tube and was incubated for 1 min at 37°C. After that 200 U of M MulV Reverse 
Transcriptase (New England BioLabs) was added and the reaction was incubated for 50 
min at 37°C. Finally the enzyme was inactivated at 70°C for 15 min and the cDNA was 
aliquoted and stored at -80°C. 
 
3.2.1.11. Lightcycler PCR 
Lygthcycler PCR allows to quantitatively estimate the amounts of gene transcripts and to 
compare them for different tissues, cells or developmental stages. The Lightcycler- 
FastStart DNA Master SYBR Green Kit allows quantifying the amount of PCR products 
by means of incorporated SYBR Green fluorescence, which is proportional to the 
amount of double stranded DNA. cDNA was used as a template for Lightcycler PCR 
reaction. A 10 μl reaction contained 1 μl of cDNA (in dilution 1:10), 1.2 μl MgCl2 (25 
mM), 1 μl of two primers (10 pmol each) and 1 μl Master SG mix (Taq DNA–
Polymerase, SYBR Green, dNTPs and 10 mM MgCl2). Lightcycler PCR was performed, 
using the Lightcycler Thermal Cycle System (Roche). The PCR program for mouse 
brain, spinal cord, C2C12 myoblasts, and C2C12 myotubes treated with inactive 0.0 or 
active 4.8 isoforms of agrin given in the Table 3.16. 
 
Step  Number 
of cycles  
Temperature Time  
Denaturation  1  95 ºC  8min  
Amplification 40  95 ºC  0 sec  
62 ºC  7 sec  
72 ºC  1min  
Elongation  1  95 ºC  30sec  
1  67 ºC  30sec  
1  95 ºC  0 sec  
  
Table 3.16: Lightcycler PCR program. 
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The amount of gene transcripts was defined for MuSK, AChR α subunit and Erbin and 
normalized to the amount of transcripts of a housekeeping gene (β-actin). Respective 
primers used for PCR reactions and sizes of resulting PCR products are listed in the 
Table (see 3.8.). 
 
3.2.1.12. Yeast-two-hybrid techniques 
The MATCHMAKER yeast-two-hybrid System 3 (Clontech) was used to identify protein-
protein interactions in yeast cells. It comprises a bait sequence expressed as a fusion to 
the GAL4 DNA-binding domain (DNA-BD) from the pGBKT7 plasmid (Table 3.11.), while 
prey sequences are expressed as a fusion to the GAL4-activation domain (AD) from 
pGADT7 or from pGAD424 (Table 3.11.). When bait and prey fusion proteins interact, 
the DNA-BD and AD of GAL4 are brought into proximity, thus activating transcription of 
reporter genes. Yeast strains HF7c and AH109 have been used for the yeast-two-hybrid 
screens. The elimination of false positives have been performed by using the reporter 
genes - HIS3, lacZ (for HF7c) and ADE2, HIS3, lacZ (for AH109), which are under the 
control of distinct GAL4 upstream activating sequences (UASs) and TATA boxes. 
For generation of bait constructs for the yeast-two-hybrid screens, different domains of 
MuSK were amplified by PCR using pMT-MuSK-full-length as a template and subcloned 
in frame into the EcoR I/Sal I restriction sites of pGBKT7 (Table 3.1). MuSK2xwt and 
MuSK2xkd baits were generated and kindly provided by the group of Prof. Hans-Rudolf 
Brenner. In brief, two intracellular domains of rat MuSK or its kinase defective mutant 
(Acc.No. U34985) were linked together by five E/G modules. As 
restriction sites for the first intracellular MuSK domain NcoI and EcoRI and for the 
second intracellular MuSK domain EcoRI and SalI of pGBKT7 were used. 
 
 
Cloning vectors  Epitope  Yeast selection  Bacterial 
selection  
pGBKT7 (bait)  myc  TRP1  kanamycin  
pGADT7 (prey)   LEU2  ampicillin  
pGAD.GH (prey)   LEU2 ampicillin  
Control vectors  Epitope  Yeast selection  Bacterial 
selection  
pGADT7-T  HA  LEU  ampicillin  
pGBKT7-53  myc  TRP1  kanamycin  
 
Table 3.18: Yeast vectors used. 
 
 
Bait MuSK domains  Aa 
position 
Primers used for subcloning 
(see Table 3.3.)  
pBridge-
agrin- 
Part between and 
signal  
 MuSK-10 + MuSK-19  
MuSK-1  sequences and IgI 
+ Ig- I 
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pBridge-
agrin- 
Part between IgI 
and Ig2  
 MuSK-10 + MuSK-20  
MuSK-2  + Ig2    
pGBKT7-
MuSK- 
whole extracellular  MuSK-10 + MuSK-21  
5  domain    
pGBKT7-JM  Juxtamembrane (JM)  481-520 MuSK-22 + MuSK-23  
pGBKT7- Two times whole  2x (467- Gift from Prof. Hans-Rudolf 
Brenner  
MuSK2xwt  intracellular 
domain  
868)   
 
Table 3.19. Bait plasmids generated for yeast-two-hybrid screens. 
 
Before starting the screens, transformation efficiency of competent yeast cells were 
analyzed in order to ensure high efficiencies while performing screens. Bait constructs 
were also tested for autonomous transactivation of yeast reporter genes. Furthermore, 
the growth kinetic of transformed yeast was not disturbed indicating the absence of 
toxicity for the bait (data not shown). Some screens were done with 3-AT (3-amino-1, 2, 
4- triazole, Sigma; 0/5/10/20 mM) in the medium. 3-AT is a competitive inhibitor of the 
histidine biosynthetic enzyme His3p protein (His3p), is used to inhibit low levels of His3p 
expressed in a leaky manner in some reporter strains (Feilotter et al., 1994). 
To screen for MuSK interacting proteins, yeast HF7c and AH109 cells were sequentially 
transformed with each bait vector and 1 μg of a human HeLa cDNA MATCHMAKER 
library (Clontech), using the lithium acetate method (Schiestl and Gietz, 1989) (see 
Table 3.18.). 
 
1x Tris EDTA (TE) pH 
7.5  
From 10x TE: 100 mM Tris-Cl, 
10 mMEDTA  
1x TE/LiAc pH 7.5  From: 10x TE, 10x LiAc  
 40% PEG 3350  
PEG/LiAc/TE pH 7.5  1x TE buffer  
1x LiAc  
DNA carrier  Yeastmaker carrier DNA  
DMSO  10% final concentration  
 
Table 3.20. Solutions for yeast transformation. 
 
The yeasts were plated on selection media (SD -Leu, -Trp) to estimate the efficiency of 
transformation and on selection media (SD -Leu, -Trp, -His or SD -Leu, -Trp, -His, -Ade) 
containing 5, 10 or 20mM 3-AT for the reporter gene activations. Yeast colonies growth 
was evaluated after 5 days of incubation at 30°C. Selected positive clones were further 
confirmed by colony-lift filter assays for β-galactosidase activity according to the 
Clontech Manual. Transformation efficiency was calculated for every screen after 
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counting colonies (c.f.u. - colony forming unit) growing on SD -Leu, -Trp dilution plates 
(1:10; 1:102; 1:103; 1:104) according to the formula:  
 
(Counted c.f.u.) * Total suspension volume (μl) 
Volume plated (μl) * Dilution factor * Amout of DNA used (μg) 
 
Prey plasmids were isolated from positive yeast colonies for all screens according to the 
Clontech Manual protocol for preparation of plasmids from yeasts and then shuttled into 
E. coli XL1-Blue electrocompetent cells to get higher quality and concentration of prey 
plasmid. Plasmids were digested with EcoR I/Xho I or Alu I restriction enzyme in order to 
get rid of identical clones based on the restriction patren. Independent clones from the 
screen were retransformed into the yeast together with respective bait or empty plasmid 
in order to confirm the specificity of the interaction and to remove the unspecific 
interaction with Gal4-DBD. Library inserts of positive, re-tested interactors were 
sequenced and analyzed with protein and nucleotide databases of the National Center 
for Biotechnology Information (NCBI, Bethesda, MD) using the Basic Local Alignment 
Search Tool (BLAST). Only candidates, whose coding sequences were in frame with the 
GAL4 AD, have been selected for further investigation. 
For binary epitope-mapping yeast-two-hybrid studies PCR-amplified intracellular 
epitopes of mouse MuSK (Acc.No. MMU37709) were subcloned into pGBKT7 using 
restriction digestion sites EcoR I and Sal I (see Table 3.21). 
 
Bait  MuSK epitope  aa 
position 
Primers used for 
subcloning (see 
Table 3.1.)  
pGBKT7-MuSK-
563  JM  467-563 
MuSK-38 + MuSK-
61  
pGBKT7-MuSK-
682  
JM + half of kinase 
domain  
467-682 MuSK-38 + MuSK-
62  
pGBKT7-MuSK-
857  
JM + kinase domain  467-857 MuSK-38 + MuSK-
63  
pGBKT7-MuSK-
868  
Whole intracellular 
domain  
467-868 MuSK-38 + MuSK-
64  
 
Table 3.21: MuSK bait constructs used in epitope-mapping experiments. 
 
Different epitopes of human Erbin (Acc.No. NM-018695.2) were PCR amplified and 
subcloned into the restriction sites EcoR I and Xho I of the prey vector pGAD.GH as 
GAL4 AD fusions (see Table 3.22). 
 
Bait  Amino acid 
position  
Primers used for subcloning (see 
Table 3.4.)  
pGAD-GH-Erbin-11  aa 1079-1371  Erbin-11/Erbin-14  
pGAD-GH-Erbin-12  aa 1200-1371  Erbin-12/Erbin-14  
pGAD-GH-Erbin-13  aa 1261-1371  Erbin-13/Erbin-14  
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pGAD-GH-Erbin-16  aa 1007-1146  Erbin-19/Erbin-16  
pGAD-GH-Erbin-17  aa 1007-1205  Erbin-19/Erbin-17  
pGAD-GH-Erbin-18  aa 1007-1266  Erbin-19/Erbin-18  
pGAD-GH-Erbin-20  aa 1007-1085  Erbin-19/Erbin-20  
 
Table 3.22: Erbin prey constructs used in epitope-mapping experiments 
 
For binary yeast-two-hybrid interaction assays transactivation of reporter genes were 
analyzed in AH109 stain on selective plates (SD -Leu, -Trp, -His). Functionality of yeast-
two- hybrid assays was always tested using the positive control plasmids pGBKT7-53 or 
pGADT7-T of the MATCHMAKER GAL4 Two-Hybrid System 3 (Clontech), encoding for 
the murine tumor suppressor protein p53 and the SV40 large T-antigen, respectively. 
 
3.2.2. Protein Biochemistry Methods 
 
3.2.2.1. Preparation of protein extract from cells and tissues 
For preparation of protein extract HEK293 cells were transfected with Superfect 
(Qiagen) and Ca-Phosphate methods in 10 cm plates. Cos7 cells were transfected in 10 
cm plates using DEAE-dextran technique followed by chloroquine treatment. Whole cell 
protein extracts were prepared from transfected HEK293 or Cos7 cells or 
nontransfected C2C12 cells. For the preparation of protein extract for MuSK, cells were 
lysed in the presence of Buffer A (10 mMm HEPES (pH 7.9), 10 mM KCl, 0.8 mM EDTA, 
0.417 M NaCl, 1% Nonidet P-40, 2 mM DTT, 10 μg/ml aprotinin and 10 μg/ml leupeptin). 
Immediately after the lyses, NaCl was added to a final concentration of 400 mM. After 
incubation for 
15 min (for HEK293 cells) or 30 min (for C2C12 cells) under constant rotation, cell 
debris was removed from the extract by centrifugation (20817 rcf for 10 min). 
In order to get Erbin lysate; we used the method describe by (Borg et al., 2000). For that 
cells were washed twice with cold PBS and lysed in lyses buffer (50 mM HEPES pH 7.5, 
10 % glycerol, 150 mM NaCl, 1 % Triton X-100, 1.5 mM MgCl2, 1 mM EGTA) 
supplemented with 1 mM phenylmethylsulphonylfluoride (PMSF), 10 μg/ml aprotinin and 
10 μg/ml leupeptin. After incubation for 30 min under constant rotation, cell debris was 
removed from the extract by centrifugation (13000 rcf for 20 min). 
For preparation of muscle tissue extract, tissues were frozen in liquid nitrogen, mashed 
and further homogenized in ice cold lyses buffer (50 mM HEPES pH 7.5, 10 % glycerol, 
150 mM NaCl, 1 % Triton X-100, 1.5 mM MgCl2, 1 mM EGTA) supplemented with 1 mM 
phenylmethylsulphonylfluoride (PMSF), 10 μg/ml aprotinin and 10 μg/ml leupeptin for 20 
min. Cell debris was removed from the extract by centrifugation (13000 rcf for 20 min). 
 
3.2.2.2. Immunoprecipitation 
For immunoprecipitation experiments HEK293 or Cos7 cells were transiently transfected 
with one of the following CMV-expression plasmids encoding for: T7- or myc-tagged 
MuSK2xwt and MuSK2xkd constructs, HA tagged full length MuSK, T7-tagged MuSK C-
terminal truncations, myc-tagged full length Erbin, T7- and myc- tagged CK2 β, 
HAMaterial and methods tagged CK2 α, HA-CK1 and HA-tagged Wnt receptors. Protein 
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extract was prepared as described above (3.2.2.1). For each extract the expression 
level of protein was analyzed by Western blot (3.2.2.7) and adjusted. Lysates containing 
expressed proteins were mixed and the final volume set to 500 μl with the buffer 
containing 50 mM HEPES pH 7.5, 10 % glycerol, 150 mM NaCl, 1 % Triton X-100, 1.5 
mM MgCl2, 1 mM EGTA. 1 μl of a monoclonal antibody against the T7- (Novagen), myc- 
or HA- (Cell Signaling) was added and the reaction was incubated under constant 
rotation at 4°C for overnight. Next, 20 μl of PBS equilibrated Protein A Sepharose CL-4B 
beads (Amersham) were added and incubation continued two hours. After washing the 
beads three times with buffer containing 50mM Hepes, pH7.5, 150mM NaCl, 1mM 
EDTA, 10% glycerol, 1mM PMSF, 10 μg/ml leupeptin, 10 μg/ml aprotinin the precipitated 
proteins were analyzed by SDS-PAGE and Western blot. 
For immunoprecipitation of endogenous Erbin and MuSK proteins from C2C12 cells or 
tissue extract, a polyclonal rabbit serum against MuSK (abcam or MuSK-Rabbit, 20 kd) 
or Erbin was pre-conjugated with Protein A Sepharose. 20 μl of antibody was incubated 
with 40 μl of Protein A Sepharose in 1 ml of PBS overnight at 4°C under constant 
rotation. Then Sepharose beads containing MuSK or Erbin antibody on their surface 
were washed two times with 500 μl of PBS and equilibrated with PBS in a 1:1 ratio. A 10 
μl aliquot of MuSK-antibody-Sepharose conjugate was added to the extracts. Samples 
were incubated under the constant rotation overnight. After washing three times with 50 
mM Hepes, pH7.5, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1m M PMSF, 10 μg/ml 
leupeptin and 10 μg/ml aprotinin, proteins bound to the Sepharose beads were resolved 
by SDS gel and analyzed by Western blot. 
 
3.2.2.3. Protein expression and extraction from bacteria 
Full length, N-terminal or C-terminal truncations of pGAD.GH-Erbin-Y2H clone were 
ligated in-frame to the coding sequence of glutathione-S-transferase (GST) in pGEXKG 
(3.2.1.6). cDNA encoding for the Juxtamembrane epitope and Kinase epitope of mouse 
MuSK were fused in frame to the His-tag of pET28b (3.2.1.6). Plasmids were 
transformed in E. coli BL21 (Rosetta). Bacteria expressing GST-fusions of Erbin were 
grown in 50 ml cultures until OD600 0.4. Protein expression was induced by 1 mM 
isopropyl-beta-D-thiogalactoside (IPTG; Sigma) for 4 h. Afterwards bacteria were 
collected by centrifugation, incubated in sonification buffer (50 mM NaH2PO4, 300 mM 
NaCl, 25 U/ml Benzonase, 10 μg/ml leupeptin, 10 μg/ml aprotinin, 1 μl/ml Triton X-100, 
10 μg/ml DNAseI, 15 U/μl Lysozym) at 4°C for 30 min, lysed by sonification and 
centrifuged (14000 rpm for 10 min). The supernatants containing the GST-fusion 
proteins were collected and used freshly for the further GST-pulldown experiments 
(3.2.2.4). 
Bacteria expressing His-tag fusions of Juxtamembrane epitope and Kinase epitope of 
mouse MuSK were grown in 4 l culture until OD600 1.0 and protein expression was 
induced by 1 mM IPTG for 4 h. Bacteria were pelleted by centrifugation. The pellet was 
dissolved in 270 ml buffer A, pH 8.0 (6 M guanidine hydrochloride, 0.1 M NaH2PO4, 
0.01 M Tris pH 8.5) and shook overnight at 250 rpm. The lysate was centrifuged to 
remove cell debris, the supernatant was collected and incubated with 6 ml Ni-NTA 
agarose (Qiagen) under constant rotation during 3 h at RT. Ni-NTA beads were washed 
five times in buffer B pH 8.0 (8 M Urea, 0.1 M NaH2PO4, 0.01 M Tris), three times with 
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buffer B pH 6.6 and the protein was eluted by washing the beads five times with 7.5 ml 
buffer B pH 4.5. 
 
3.2.2.4. GST-pulldown 
The supernatants containing the GST-fusion proteins were supplemented by 30 μl 
equilibrated Glutathione-Sepharose beads and incubated under constant rotation at 4°C 
for 2 h. After washing three times with washing buffer containing 4.3 mM Na2HPO4, 1.47 
mM KH2PO4, 1.37 mM NaCl, 2.7 mM KCl an aliquot of the beads was loaded on a SDS 
gel for estimation of the concentration by a Coomassie Brilliant Blue (Roche) staining. 
Then the beads carrying the GST-fusion protein were incubated together with 25 μl of 
extract from cells expressing the desired protein after transient transfection. After 
washing three times with the washing buffer, proteins bound to the beads were 
analyzed by SDS-PAGE and Western blot. 
 
3.2.2.5. Electrophoresis of proteins 
Proteins were resolved on denaturing SDS polyacrylamide gels, using the Vertical 
Minigel system (Sigma). The separating gel contained 8, 10, 12.5 or 15% 
polyacrylamide depending on the molecular weight of the protein and the stacking gel 
was always 5% (see Table 3.24). The proteins were mixed with sample loading Lammli 
buffer, denatured at 100°C for 5 min and loaded on the gel. Electrophoresis was carried 
out constantly at 80 or 100V for 1-2 h in SDS gel running buffer depending on the 
protein dimensions. 
 
Separating gel buffer  1.5 M Tris-Base 
pH 8.8, 0.4% (w/v) 
SDS  
Stacking gel buffer  500 mM Tris-HCl 
pH 6.8, 0.4% (w/v) 
SDS  
10 x Running buffer  250 mM Tris-Base 
pH 8.3, 1.92 M 
Glycin 1% (w/v) 
SDS  
 
Table 3.23: Solutions for SDS-PAGE. 
 
 
Separating gel  8%  10% 12.5% 15 %  Stacking gel  5%  
H2O  2.9 ml  2.5 ml  2 ml  
1,5 
ml  H2O  
1.5 
ml  
Separating gel 
buffer  1.5 ml  
1.5 
ml  1.5 ml 
1.5 
ml  Stacking gel buffer  
625 
μl  
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Acrylamide/Bisacryl 
amide (30%)  
1.625 
ml  2 ml 2.5 ml 3 ml 
Acrylamide/Bisacrylami 
de (30%)  
425 
μl  
APS (20% w/v)  22.5 μl  
22.5 
μl  
22.5 
μl  
22.5 
μl  APS (20% w/v)  5 μl 
TEMED  5 μl  5 μl  5 μl  5 μl  TEMED  2 μl 
 
Table 3.24: Separating gels and stacking gel for SDS-PAGE (calculated for one gel of 
11 cm x 8 cm x 0.7 mm size). 
 
3.2.2.6. Staining of protein gels 
Coomassie staining was used to detect proteins in SDS polyacrylamide gels. After 
electrophoresis, the gel was placed in the staining solution (30% Methanol, 10% acetic 
acid, 0.05% Coomassie Brillant Blue) for 15 min at RT and then destained overnight in a 
solution containing 25% Methanol and 15% acetic acid. The gel was dried on Whatman 
paper covered with a cellophane sheet on a Gel dryer SE1160 (Hoefer Scientific 
Instruments). 
 
 
3.2.2.7. Western blot 
Proteins resolved on SDS polyacrylamide gels were transferred to nitrocellulose 
membrane in blotting buffer (see Table 3.25) for ~1.5 h at 150 mA. The membrane was 
then blocked in blocking buffer (see Table 3.25) for 1 h at RT and further incubated for a 
minimum of 1 h up to overnight with the first antibody diluted in washing buffer (see 
Table 3.25). A monoclonal antibody directed against the T7-tag (Novagen), myc-tag, 
HA-tag (Cell Signaling) and or polyclonal sera against either Erbin (Gift from Borg et al., 
2000) or MuSK (ABR, abcam, 194T or 20kD) served as primary antibodies. 1:10000 
dilution was used for anti-T7, HA-tag and anti-myc-tag antibodies; 1:100 for all 
polyclonal antibodies (except 1:3000 for α-MuSK 20kD). The membrane was washed 
three times for 5 min with the washing buffer, incubated for 1 h with secondary antibody 
(Horseradish-peroxidase-coupled-Protein A or anti-mouse-Ig-coupled-
horseradishperoxidase in 1:3000 dilution), and subsequently washed three times for 5 
min with the washing buffer. The bound antibodies were detected by the ECL system 
(Amersham) according to the manufacturer’s protocol, and the membrane was exposed 
to X-ray film super RX (FUJI Medical) that was developed in a film developer X-Omat 
1000 Processor (Kodak). 
 
Blotting buffer  480 mM Tris, 380 mM Glycin, 0.1% SDS, 
20% Methanol  
Blocking buffer  PBS, 0.1% Tween-20, 5% dry milk 
powder  
Washing buffer  PBS, 0.1% Tween-20  
 
Table 3.25: Western blot buffers 
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3.2.3. Cell culture methods 
 
3.2.3.1. Cultivation of HEK293, Cos7, C2C12 and MuSK-deficient myoblasts 
HEK293 or Cos7 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; 
Gibco/BRL) containing 10% (v/v) fetal calf serum (FCS; Invitrogen) at 37°C and 5% 
CO2. C2C12 cells were maintained for proliferation in DMEM containing 20% (v/v) FCS, 
for differentiation the medium was replaced by DMEM with 5% (v/v) heatinactivated 
horse serum (HS, Invitrogen) at the same growth conditions. Myotubes were formed 
after 4-6 days. 
 
3.2.3.2. Transient transfection of cells 
24 h before transfection exponentially growing cells were replated in growth medium and 
transfected at 50-60% (HEK293, Cos7) or 80-90% (C2C12, MuSK-deficient myoblasts) 
confluence.  
 
A. Superfect transfection 
For preparation of protein extracts HEK293 cells were transiently transfected with CMV 
expression plasmids (see 3.2.1.6) in 10 cm dishes with 10 μg of expression vectors 
using Superfect (Qiagen). In order to test the efficiency of siRNAs against Erbin RNA 
HEK293 cells were transfected in 6 cm plates with 0.2 μg of CMV-expression vectors 
encoding for Erbin cDNA together with 1.8 μg of the respective pSUPERneoGFP(E797)-
siRNA constructs. For 10 cm plate transfection DNA was dissolved in 300 μl of DMEM 
medium lacking FCS. Then 30 μl of Superset reagent was added to the DNA solution 
and mixed by vortexing for 10 sec. The samples were incubated for 5-10 min at RT to 
allow transfection complex formation. In the meantime the growth medium was aspirated 
from the dishes and the cells were washed once with 4 ml of PBS. Then 4 ml of cell 
growth medium (containing FCS) were added to the reaction tube containing the 
transfection complex, mixed by pipetting and immediately transferred to the cells. Cells 
were incubated with the transfection complexes for 3-12 h under their normal growth 
conditions. After that the medium containing the remaining complexes was removed 
from the cells, cells were washed once with 4 ml of PBS and fresh growth medium was 
added. Transfection efficiency was controlled by transfection of one cell plate with the 
plasmid expressing Green Fluorescence Protein (GFP) with nuclear localization signal 
pnlsGFP (Hashemolhosseini et al., 2000). At 48 h post-transfection, cells were 
harvested for extract preparation as described (see 3.2.2.1.). 
B. Calcium Phosphate transfection 
In some cases HEK-293 cells were transfected using the Calcium Phosphoate 
technique. Transfection reaction for 10 cm plates was made as follows: 10 μg of 
expression plasmid DNA was mixed with 800 μl water and 100 μl 10x HEBS (1.4 M 
NaCl, 50 mM KCl, 50 mM Glucose 7.25 mM Na2HPO4 and 210 mM HEPES, pH 7.2). 
100 μl 1M CaCl2 was added to the transfection mixture. Mixture was votrex immediately 
for 30 second. The transfection mixture was incubated at room temperature for 45 
minutes. The mixture was mixed again and added to the growth medium of the cells. 
After incubation for three hours under standard growth conditions, the medium was 
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replaced by 8 ml of fresh medium. At 48 h post-transfection, cells were harvested for 
extract preparation as described (see 3.2.2.1.). 
C. DEAE-Dextran transfection 
In some cases Cos7 cells were transfected using the DEAE-Dextran technique. The 
transfection reaction for 10 cm dish was made as follows: 10 μg of expression plasmid 
DNA were mixed with 187.5 μl of PBS and 375 μl of DEAE-Dextran. The mix was added 
to the growth medium of the cells. After incubation for 30 min under standard growth 
conditions, the medium was replaced by 8 ml of fresh medium and 80 μl of Chloroquin 
was added. Cells were incubated for 3 h, and then the growth medium was changed 
once again. At 48 h post-transfection, cells were harvested for extract preparation as 
described (see 3.2.2.1.). 
D. LipofectamineTM 2000 transfection 
For immunocytochemistry C2C12 cells were transiently transfected in 3.5 cm plates with 
either 0.4 μg of plasmid expressing nuclear localized GFP - pnlsGFP together with 3.6 
μg pSUPERneoGFP (E797)-siRNA constructs or 1 μg of plasmid expressing nuclear 
localized GFP - pnlsGFP together with 3 μg pRK5-myc-Erbin constructs. 24 h before 
transfection cells were replated in growth medium without antibiotic. 4 μg of DNA was 
dissolved in 250 μl of DMEM medium lacking FCS. 10 μl of Lipofectamine was diluted 
separately in 250 μl DMEM medium lacking FCS. After incubation for 5 min at RT the 
mixtures were combined and incubated for 20 min at RT. Then 500 μl of 
DNALipofectamine complex was added to each plate. The medium was replaced by 
differentiation medium after one day. 
 
3.2.3.3. Luciferase reporter test 
The ATP dependent oxidation of luciferin by luciferase is accompanied by the light 
emission, which can be measured. The luciferase activity test was performed to check 
the ability of different siRNAs to knockdown the mRNAs of Erbin. The cDNAs of the 
respective genes were subcloned together with the luciferase gene to be transcribed as 
a bicistronic message (see 3.2.1.6.). An effective siRNA would target the chimeric 
luciferase-Erbin mRNA which would result in its degradation and lead to a decrease of 
luciferase activity. HEK293 cells transfected with the constructs described above were 
lysed 48 h posttransfection. The lyses of the cells was performed in 300 μl per well of 
Luciferase Harvest/Assay Buffer, which contained 88 mM Tris/MES pH 7.8, 12.5 mM 
MgAc, 2.5 mM ATP, 1 mM DTT and 0.1% Triton X-100. Measuring of the 
chemiluminescence reaction was performed for 200 μl of the cell lysate in a luminometer 
(Berthold–Lumat LB9501), after injection of 100 μl of 0.5 mM luciferin dissolved in 5 mM 
KHPO4. The luciferase activity was calculated in Relative Light Units (RLU). 
 
3.2.3.4. Agrin treatment 
The production of agrin-conditioned media was performed as described before (Kröger, 
1997). In brief, stably transfected HEK293 cells (gift from Dr. Stephan Kröger) 
expressing continuously secreted active agrin 4.8 or inactive agrin 0.0 were grown in 
DMEM containing 10% FCS until 80-90% confluence. After another 4 days of 
proliferation in serum-free DMEM, agrin-conditioned medium was collected, aliquoted 
and frozen. Agrin-conditioned medium was added at 1:8 dilution (125 μl per 3.5 cm dish) 
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to C2C12 myotubes. AChR aggregates were detected or quantified 16 h later as 
described 
below (see 3.2.3.5.). 
 
3.2.3.5. Immunocytochemistry 
AChR clusters on the surface of C2C12 were visualized by α-Bungarotoxin staining. 0.5 
μl Rhodamine-conjugated-α-Bungarotoxin (Rh-α-BTX) was added in the medium and 
cells were kept for 1 h in the growth chamber. Cultivation medium was aspirated from 
the dishes and cells were washed three times with PBS. Then cells were fixed with 2% 
PFA solution in PBS for 20 min at RT. After washing three times with PBS the bottoms 
of the dishes with cells on their surface were cut out and mounted on cover slides with 
Mowiol. Slides were analyzed and documented using the Cy3 filter of a Leica inverted 
microscope (DMIRB) equipped with a cooled MicroMax CCD camera (Princeton 
Instruments, Stanford, CA). 
 
 
3.2.3.6. Quantification analysis of AChR clusters 
The numbers of AChR aggregates were quantified as follows: using the Cy3 filter 
pictures were taken from myotubes randomly expressing nuclear localized GFP – pnls 
GFP. AChR clusters were counted for each myotube. Quantification analysis of AChR 
clusters was performed for three independent experiments. 
 
3.2.3.7. Immunohistochemistry 
For immunohistochemical analysis, all muscles were quick-frozen in prechilled 
isopentane and embedded in Tissue-Tec (Leica Instruments). Muscles from adult mice 
were cryotome-sectioned to 12 μm slices and placed on glass slides (HistoBond, 
Adhesion Micro Slides, Jung HistoService). Sections were air-dried for 1 h at RT and 
stored at -80°C or directly subjected to the immunohistochemical staining. Unfixed 
sections were rinsed with PBS and permeabilized for 5-10 min in PBS supplemented 
with 0.1% Triton-X100, blocked in 10% fetal calf serum and 1% bovine serum albumin 
for 1- 2 h. Cryotome sections were stained for AChR with Alexa-α-Bungarotoxin or 
Rhodamin-α-Bungarotoxin at 1:2,500 dilution (BTX; Molecular Probes, Eugene, OR) or 
incubated with anti-Erbin (1:100) (gift from Dr. Jean Paul). As MuSK specific antibodies 
either a self-made antibody (anti-MuSK20kd; 1:100) was used or anti-MuSK (1:100) 
which was kindly provided by Markus Ruegg. Incubation was done in the blocking 
solution at 4°C in a humid environment overnight. After washing the sections six times 
for 5 min in PBS, secondary antibodies conjugated to Cy2, Cy3 or Alexa 488 
immunofluorescent dyes (Dianova, Molecular probes) were applied in 1:100, 1:200 or 
1:500 dilutions respectively for 1 h at RT. Subsequently, sections were washed six times 
for 5 min in PBS and covered with Mowiol. 
For immunohistochemical analysis, rat retinae were fixed with 2% PFA for 30 min, 
washed several times with PBS and embedded in Tissue-Tec (Leica Microsystems, 
Wetzlar, Germany). Frozen tissue was sectioned to 10 μm slices. Sections were rinsed 
with PBS and permeabilized for 5-10 min in PBS supplemented with 0.5 % Triton-X100, 
blocked in 10% fetal calf serum (FSC) and 1% bovine serum albumin (BSA) for 1-2 h. 
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Sections were stained with anti-MuSK antibodies from rabbit (Rb194T, recognizing an 
extracellular epitope, 1:1,000, gift from Markus Ruegg; for simplicity this antibody is 
named αMuSK throughout the manuscript) or from guinea pig (gpMuSK-20kd, 
recognizing an intracellular epitope, 1:1,000), mouse anti-GFAP (1:500, Chemicon, 
Temecula, CA), mouse anti-glutamine synthetase (1:500, BD Transduction Laboratories, 
San Diego, CA), mouse anti-choline acetyltransferase (1:1,000, Chemicon), mouse anti- 
Thy1 (1:500, BD Transduction Laboratories) and mouse anti-agrin (AGR-540, 1:500, 
Stressgen). Secondary antibodies conjugated to Cy2 or Cy3 immunofluorescent dye 
(1:200, Dianova, Hamburg, Germany) were used. Staining with Rb194T antibody 
preincubated for 2 h with lysate of HEK293 cells containing MuSK protein or preimmune 
serum of gpMuSK-20kd served as negative control. Co-immunostainings with primary 
antibodies from the same species were performed in a sequential manner. Cross-
reaction of secondary antibodies was excluded by running in parallel negative controls 
without the second primary antibodies. Additionally, retina sections were co-stained with 
DAPI (1:1,000, Sigma-Aldrich, Deisenhofen, Germany). Results were documented using 
a Leica inverted microscope (DMIRB) equipped with a cooled MicroMax CCD camera 
(Princeton Instruments, Trenton, NJ) or Leica confocal microscope TCS SL equipped by 
Leica confocal software TCS SL version 2.5.1347a. 
 
4. Results 
 
4.1. Yeast-two-hybrid screens 
 
4.1.1. Generation of MuSK baits 
For the bait consisting of the juxtamembrane domain of MuSK aminoacids 481 to 520 
was subcloned in frame with GAL4-DNA-BD in pGBKT7 (Fig. 7). For the generation of 
MuSK2xwt bait two complete intracellular domains of MuSK were fused by a flexible G/E 
linker) thereby creating a dimer most likely resembling the in vivo active MuSK dimmer 
(Fig. 7). A second fusion was generated the same way for a kinase defective MuSK 
variant, bearing substitution of lysine in the ATP binding site (Zhou et al., 1999) of the 
kinase domain (named MuSK2xkd) to explore if binding depends on the phosphorylation 
of the intracellular domain of MuSK (Fig. 7). These two baits were kindly provided by the 
group of Dr. Hans-Rudolf Brenner (Biocenter, Basel, Switzerland). 
 
Fig.7: JM representing juxtamembrane domain and MuSK2xwt mimicking kinase-active 
dimeric MuSK were used for identification of MuSK intracellular downstream effectors. 
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Candidates from yeast-two-hybrid screen with MuSK2xwt were checked for interaction 
with kinase defective MuSK2xkd bait. 
 
4.1.2. Outcome of the yeast-two-hybrid screens 
Outcome of the yeast-two-hybrid screens is summaries in the Table 4.1. In all screens, 
the number of examined colonies was higher than the number of independent clones of 
the library to ensure that statistically every clone of the library was tested at least one 
time. 
 
 
Bait Conditions  No of  Candidates  Confirmed  Potential MuSK  No of  Amino  
  independent    binding partners  identification  acid  
  clones      Sequence  
  screened       
        
MuSK2xwt  T-L-H -
5mM 3AT 
1,3 x 106  210  26  CK2 β 
BC003775  
89  1-215  
     Erbin  2  1007- 
 T-L-H-A- 3,2 x 106  99  11  NM_018695.2   1371  
 20 mM 
3AT  
   Phosphatase2A 
BC002657.2  
1  
5-309  
     Stat5B  1   
     NM_012448.3   565-787  
        
MuSK-JM  T-L-H- 1,1 x 106  34  3  - - - 
 5mM 3AT       
 
Table.4.1: Results of the yeast-two-hybrid screens with the MuSK domains. 
Only relevant candidates, e.g. with the corresponding tissue expression, signaling 
pathways and sub-cellular localization to that of MuSK, are shown in the column 
“potential MuSK binding partners”. The number of independent sequences and amino 
acid region of candidate obtained from the yeast-two-hybrid screen are indicated. 
 
One of the candidates, which have been identified many times in the yeast-two-hybrid 
screen with the MuSK intracellular domain, is the regulatory β subunit of protein kinase 
CK2 (the holoenzyme was formerly called casein kinase 2). CK2 is a highly conserved 
and ubiquitously expressed serine/threonine kinase, which is involved in many biological 
processes such as gene expression, protein synthesis and signal transduction (Meggio 
and Pinna, 2003; Olsten and Litchfield, 2004). 
Among the other clones identified, two clones consisted of the carboxyterminal part 
beginning at amino acid residue 1007 until the stop codon of the LAP protein family 
member Erbin (Erbin-N∆-1007). 
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4.3. Detailed investigation of MuSK - Erbin interaction 
To evaluate the significance of the interaction between MuSK and Erbin following 
experiments have been performed: 
- Investigation of the temporal and spatial expression profile of Erbin at the NMJ 
- Co-localization of MuSK and Erbin proteins at the NMJ 
- Biochemical verification of the interaction between MuSK and Erbin 
- Mapping of the binding epitopes for both proteins 
- Investigation of the biological significance of the interaction between MuSK and Erbin 
WB:α-HA (CK1) 
 
4.3.1. Quantitative determination of Erbin transcript level in different 
tissues 
Given that Erbin and MuSK interact physically, we sought to determine the spatial 
expression profile of Erbin in synaptic and extrasynaptic regions of skeletal muscle. 
Considering the fact that transcripts of MuSK as well as other proteins of postsynaptic 
specialization, for example AChR subunits, are upregulated at the synapse (Witzemann 
et al., 1991; Moore et al., 2001), we intended to investigate whether the same is true for 
Erbin. By quantitative real-time PCR we measured the quantity of transcripts of Erbin 
and compared them with transcript amounts of molecules known to accumulate at the 
NMJ, such as MuSK and AChRα. 
For 1st strand cDNA preparation, we used RNA from mouse synaptic and extrasynaptic 
region of the diaphragm, C2C12 myoblasts and C2C12 myotubes. The C2C12 
myotubes were treated with conditioned media containing either nerve-derived or 
muscle-derived agrin. As control, we used 1st strand cDNA from mouse brain which 
should contain only marginal amounts of MuSK transcript. As expected, the amount of 
MuSK and AChRα mRNA accumulated both in the synaptic region of the diaphragm and 
in C2C12 myotubes especially after treatment with the nerve-derived agrin isoform (Fig. 
11a, 11b). 
The quantity of transcripts of Erbin was significantly higher in muscle tissue compared to 
brain, with Erbin transcript levels higher in the synaptic vs. extrasynaptic part of the 
diaphragm (Fig. 11c). C2C12 myotubes contained a slightly higher amount of Erbin 
transcript than myoblasts. Erbin transcript levels were even higher in response to 
nervederived agrin (Fig. 11c). Finally, we confirmed the formation of PCR-derived Erbin 
DNA fragments by agarosegel electrophoresis (Fig. 11d). 
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Fig.11: Distribution of transcripts of AChRα, MuSK and Erbin at the postsynapse. 
Realtime quantitative PCR data show the distribution of different transcripts in brain 
(used as control), extrasynaptic or synaptic diaphragm, C2C12 myoblast, C2C12 
myotubes treated either with muscle-derived agrin or a nerve-derived agrin isoform (for 
16h) which is very potent in its ability to aggregate AChRs. The setup was verified by 
measuring the transcript quantities of known players at the NMJ, such as MuSK (a) or 
AChRα (b). Similarly, the distribution of ranscripts for Erbin was studied (c). The PCR-
amplified Erbin fragments were verified by agarosegel electrophoresis (d). Since relative 
quantification data normalized to β-actin are shown, C2C12 myoblast levels are always 
set to 1. Interestingly, even bath-applied nerve-derived agrin which was not anchored to 
the surface of the petridish by precoating the dish with laminin or Matrigel (Becton 
Dickinson) led to an increase of AChR transcript levels in C2C12 myotubes. 
 
 
 
4.3.2. Localization of Erbin at the NMJ 
Previously, Erbin was detected at postsynaptic specializations of the hindlimb muscle of 
mice (Huang et al., 2001). We also observed by immunohistochemical co-staining of 
cross-sections of gastrocnemius and soleus mouse (hindlimb) muscle a significant 
accumulation of Erbin at the NMJ where it perfectly co-localized with synaptic AChRs 
(Fig. 12a). Preterminal localisation of Erbin was excluded by the observation that 
colocalization of both Erbin and AChR markers remained five days after nerve resection, 
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i.e. when presynaptic terminals had degenerated (Fig. 12b). Additionally, we confirmed 
using the same muscle cross-sections like before direct co-localisation between Erbin 
and MuSK (Fig. 12c). But these observations still does not rule out a possible co-
localization of AChRs with Schwann cell derived Erbin. For that, we investigated co-
localization of Erbin and AChRs in wildtype electrically active muscles by recombinant 
neural agrin, which induced ectopic postsynaptic membranes known to be free of 
Schwann cells (Fig. 13a, b). We confirmed by confocal microscopy a perfect co-
localization of both Erbin and ectopic AChR aggregations (Fig. 13b). 
 
Fig.12: Erbin co-localizes with postsynaptic specializations in vivo. 
Frozen 12μm thick cryotome cross-sections of surgically dennervated (5d post-
operation) or innervated (contralateral) mouse hindlimb muscle immunostained with BTX 
(shown in red) and an Erbin reactive antibody (shown in green) (a, b). Note, the 
colocalization between Erbin and postsynaptic specializations is present in the absence 
of the nerve in the denervated state. To verify co-localization between MuSK and Erbin, 
muscle cross-sections were also stained with MuSK and Erbin recognizing antibodies 
(c). Scale bar, 20 μm (the figure is kindly provided by Tatiana Cheusova). 
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Fig.13: Erbin co-localizes with postsynaptic specializations in vivo. 
To exclude a possible Erbin staining of terminal Schwann cells, ectopic postsynaptic 
membranes were generated according to a previously described methodology, as 
illustrated in (b), by intracellular injection of nerve-derived agrin and a nuclear localized 
GFP into single myotubes (Escher et al., 2005). Subcellular colocalization of BTX and 
Erbin at ectopic postsynaptic membranes (a). Note, in panel (a) a single projected image 
of a set of Z-images obtained by confocal microscopy is shown. Scale bar, 80. 
 
4.3.3. Verification of the interaction between Erbin and MuSK in HEK293 cells, 
myotubes and muscle extracts 
To biochemically confirm the interaction between Erbin and MuSK outside of yeasts, we 
transiently transfected HEK293 cells with Erbin alone or together with MuSK2xwt or 
MuSK2xkd. We immunoprecipitated proteins from these cell extracts with an antibody 
reactive against the T7 tag of the MuSK mutants and observed co-precipitation of full 
length Erbin (Fig. 14a). Even if we transfected full length MuSK in HEK293 cells we 
detected co-precipitation of Erbin by MuSK (Fig. 14b). To analyze whether the 
interaction between Erbin and MuSK also occurred in a physiological context, we used 
either C2C12 extract or tissue extract from muscle, where Erbin and MuSK are 
endogenously coexpressed (Fig. 14c, d). When we precipitated Erbin or MuSK from 
these extracts, we were also able to coprecipitate the endogenous complementary 
protein (Fig. 14c, d). These data demonstrate that Erbin and MuSK interact with each 
other in vivo. 
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Fig.14: Verification of the interaction between Erbin and MuSK by co-immunprecipitation 
studies. 
Images of Western blots decorated with an anti-T7, anti-hemaglutinin, anti-Erbin or anti-
MuSK antibody as indicated are shown. (a) Extracts of transiently transfected HEK293 
cells were used to precipitate either MuSK2xwt or MuSK2xkd and detect for co-
precipitation of transfected Erbin. (b) The precipitation of full-length MuSK in extracts 
from transiently transfected HEK293 cells led to co-precipitation of Erbin. Co-precitability 
of both proteins from endogenous origin could be demonstrated in C2C12 and muscle 
cell extracts (c, d). 
 
4.3.4. Mapping of epitopes of MuSK interacting with Erbin 
To map the epitopes of MuSK and Erbin interacting with each other, we used the MuSK 
protein and a series of carboxyterminal truncations thereof (Fig. 15a). We used Erbin- 
N∆-1007 as bait in yeast-two-hybrid assays and found growth of the yeast which proved 
interaction between bait and prey constructs only if the MuSK kinase domain was not 
cut away (Fig. 15b). We re-used the same truncations of MuSK to perform GST 
pulldown experiments with a GST tagged Erbin-N∆-1007 protein (Fig. 15c). The same 
carboxyterminallys truncated MuSK variants as used for yeast-two-hybrid assays were 
pulled down in these experiments. Finally, we transiently transfected again the MuSK 
constructs trimmed at their carboxytermini together with myc tagged full length Erbin 
protein in HEK293 cells (Fig. 15d). Using these cell extracts, co-immunoprecipitation 
was also observed with the intracellular part of MuSK containing the MuSK kinase 
domain (Fig. 15d). Altogether, we demonstrated by (i) yeast two-hybrid assays, (ii) GST 
pulldown experiments, and (iii) co-immunoprecipitation studies that the kinase domain 
ofMuSK is required for binding to Erbin. 
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Fig.15: The interaction between MuSK and Erbin requires the juxtamembrane together 
with the kinase domain of MuSK. 
(a) Schematic presentation of generated MuSK mutants containing carboxyterminal 
truncations of the intracellular domain for the use in yeast-two-hybrid experiments, GST 
pulldown assays, and co-immunprecipitation studies. (b) Growth of yeast clones 
containing different combinations of bait and prey plasmids as indicated on agar lacking 
histidine and adenine. Apart from the positive control, only yeasts containing baits 
composed of MuSK mutants bearing at least the whole kinase domain are able to 
interact with Erbin as prey. (c, d) Western blots demonstrating that by GST pulldown and 
co-immunprecipitations MuSK mutants lacking any part of their kinasedomain are 
unable to interact with Erbin. 
4.3.5. Mapping of epitopes of Erbin interacting with MuSK 
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Our next purpose was to identify the area of Erbin-N∆-1007 which interacts with MuSK. 
To this end, we generated a large number of Erbin constructs, truncated at either the 
aminoterminal or carboxyterminal parts or even at both end (Fig. 16a). The latter 
constructs were generated such that they, as depicted, represent slightly overlapping 
fragments spanning from the amino- to the carboxyterminus of Erbin-N∆-1007 (Fig. 
16a). First, we transformed the Erbin-N∆-1007 prey constructs trimmed at their amino- 
or carboxytermini together with a bait plasmid bearing MuSK2xwt into yeast. Only yeast 
cells which contained in addition to MuSK2xwt an Erbin fragment starting at amino acid 
residue 1200 were able to grow on selective agar medium (Fig. 16b). Considering the 
Erbin fragments which were trimmed at their carboxyterminus, only the one beginning 
with amino acid residue 1007 and ending at 1204 mediated interaction with MuSK2xwt 
(Fig. 16c). Further, we confirmed these epitopes of Erbin which interact with MuSK by 
GST pulldowns (Fig. 16d, e). Since our yeast-two-hybrid studies and GST pulldowns 
indicated a two partite area around amino acid residue 1200 of Erbin involved in binding 
to MuSK, we created a series of GST tagged fragments representing areas of the Erbin 
protein between amino acid residue 1007 and the end of the protein (Fig. 16a). We 
purified these GST-Erbin constructs from bacteria and used them to investigate which of 
these Erbin fragments enabled to pull down transiently transfected MuSK2xwt from 
HEK293 cell extracts (Fig. 16f). The GST pulldown assay showed that the area of Erbin 
comprising amino acid residues between 1175 and 1229 is necessary for the interaction 
between Erbin and MuSK (Fig. 16f). 
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Fig.16: Identification of the epitope of Erbin which interacts with MuSK. 
(a) Illustration of the creation of different amino- and carboxyterminal truncations of 
Erbin used for yeast-two-hybrid studies and GST pulldowns. (b, c) Growth of yeast 
clones containing different combinations of bait and prey plasmids as indicated on agar 
lacking histidine. Apart from the positive controls, only yeasts containing bait plasmids 
composed of Erbin mutants bearing the region between amino acids 1201 and 1279 
show the ability to interact with MuSK.  
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4.3.6 The Smad-interacting domain of Erbin mediates the interaction with the 
kinase domain of MuSK 
To map the epitopes of MuSK and Erbin interacting with each other, we used a series of 
carboxy-terminal truncations of MuSK . First, in yeast two-hybrid assays we observed 
growth of the yeast only when hErbin-N∆-1007 was used as bait together with the prey 
constructs MuSK-515-868 and MuSK-515-857 which comprise the full length MuSK 
intracellular or the MuSK kinase domain, respectively. Next, we transfected HEK293 
cells with expression plasmids for the same truncations of MuSK. GST pull down 
experiments with a GST tagged hErbin-N∆-1007 protein from the cell extracts  showed 
that the same carboxy-terminally truncated MuSK variants, MuSK-515-868 and MuSK-
515-857, able to promote the growth of yeast were pulled down. Next we sought to 
identify the part of hErbin-N∆-1007 interacting with MuSK. To this end, we generated 
several hErbin-N∆-1007 deletion mutants, truncated at either their amino-terminal or 
carboxy-terminal ends. First, we transfected each of the hErbin-N∆-1007 mutants as 
preys together with a bait plasmid bearing MuSK2xwt into yeasts. Only yeast cells which 
contained, in addition to MuSK2xwt, the Erbin fragment deleted up to amino acid residue 
1200 (hErbin-N∆-1200), like hErbin-PDZ (= hErbin-N∆-1261), grew on selective 
medium. When the hErbin-N∆-1007 fragments were trimmed at their carboxy-terminus, 
only yeasts containing Erbin starting from amino acid residue 1007 and ending at amino 
acid residue 1266 (hErbin-∆PDZ) or 1204 (hErbin-1007-1204) grew on selective 
medium. Further, we confirmed the epitopes of Erbin which interact with MuSK by GST 
pull downs. Since, based on our yeast two-hybrid studies and GST pull downs, aa 1145 
to 1261 were required for interaction, but, on the other hand, regions comprising aa 
1145 to 1204 or 1200 to 1261 might be sufficient for interaction with MuSK2xwt, we 
continued to define more precisely the area of Erbin most important for this interaction. 
To this end we created a series of overlapping GSTtagged fragments representing parts 
of the hErbin-N∆-1007 protein. After purification these GST-Erbin constructs from 
bacteria, we incubated them with HEK293 cell extracts containing MuSK2xwt to identify 
those able to pull down MuSK2xwt. These experiments showed that the area of hErbin-
N∆-1007 comprising aa 1175 and 1229 is required for the interaction between Erbin and 
MuSK. This area is encoded by the 3’-end of exon 21 and 5’-end of exon 23, because 
hErbin-N∆-1007 is part of splice variant hErbin-v2 which lacks exon 22. We generated 
more mutants of hErbin-N∆-1007 which were used in GST pull down assays to find out if 
epitopes encoded by both exons 21 and 23 are necessary for hErbin-N∆-1007 to 
interact with MuSK2xwt. Our results narrowed down the MuSK binding domain of 
hErbin-N∆-1007 to amino acid residues 1145 to 1211 which are encoded only by exon 
21. Conspicuously, the identified MuSK binding domain nearly overlaps with a recently 
identified Smad-interacting domain of Erbin (Dai et al., 2007). Therefore, we asked 
whether muscle cells expressed different isoforms of Erbin at the NMJ, some with and 
others without exon 21. PCR studies with Erbin splice variant-specific primers and 1st 
cDNA, reverse transcribed from total RNA of C2C12 cells or diaphragms from mice, 
revealed three different Erbin transcripts. Next to the hErbin-v2 transcript, C2C12 cells 
and diaphragm express a full length Erbin transcript and a variant which lacks both 
exons 22 and 23. Note, the bands for the three different spliced transcripts of Erbin 
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appear in similar ratios regardless whether RT-PCRs were performed using total RNA 
from C2C12 myoblasts, muscle- or nervederived agrin treated myotubes, or synaptic or 
extra-synaptic parts of diaphragms. Next, we examined whether the same area of Erbin 
will interact with full length MuSK, as it did by GST pull down assays with MuSK2xwt. 
First, we generated three additional different Erbin variants cloned in expression 
plasmids: (1) a full length containing the splice variant which lacks exons 22 and 23, (2) 
a variant which specifically lacks the MuSK binding domain, (3) solely the MuSK binding 
domain (Fig. 17a). The expression of each variant was verified by immunodetection 
using cell extracts of transiently transfected HEK293 cells (Fig. 17b). Each Erbin variant 
was then co-expressed with full length MuSK, and the cell extracts were used for co-
immunoprecipitation studies (Fig. 17c-e). Precipitating only the MuSK binding domain of 
Erbin, full length hErbin-v2, mErbin∆exon22/23, or full length mouse Erbin caused 
coprecipitation of full length MuSK, but not hErbin∆MuSK-bd (Fig. 17c, d). This indicates 
that the MuSK binding domain of Erbin is sufficient to interact with MuSK and that other 
epitopes of Erbin do not contribute to this interaction (hErbin∆MuSK-bd does not co-
precipitate MuSK, Fig. 17d). To further assess if all three proteins ErbB2, Erbin, and 
MuSK concomitantly interact and form a trimeric complex, we purified GST-tagged 
recombinant Erbin variants, composed of hErbin-N∆-1007, hErbin-PDZ, or hErbin 
MuSK-bd, and incubated them with full length MuSK or ErbB2- containing HEK293 cell 
extracts (Fig. 17d, e). Indeed, pulling down hErbin-N∆-1007 allowed coprecipitation of 
full length ErbB2 and MuSK (Fig. 17e). If HEK293 cell extracts additionally contained 
hErbin-PDZ or hErbin-MuSK-bd the co-precipitation of ErbB2 or MuSK was abolished, 
respectively (Fig. 17e). As control, human Erbin-PDZ or Erbin-∆PDZ were able to 
precipitate only ErbB2 or MuSK, respectively, from an ErbB2- and MuSK-containing 
HEK293 cell extracts (Fig. 17e). It has been reported that Neuregulin stimulates 
transcription of the ε-subunit of the AChR (Si et al., 1997). Here, we used a AChR ε-
subunit reporter gene which was previously shown to be inhibited by Erbin (Huang et al., 
2003). This inhibition was assigned to the LRR domain of Erbin (Dai et al., 2005). We 
asked whether Erbin mutants either lacking or solely composed of the MuSK binding 
domain might influence Neuregulin-mediated AChR ε-subunit reporter gene activation. 
C2C12 cells were transiently transfected with the reporter gene together with hErbinv2 
or either of the Erbin mutants, myoblasts were extracted after 48 hours or after myotube 
formation, and luciferase activities assayed. As shown before, we demonstrate that 
Erbin inhibits AChR ε-subunit reporter gene transcription in C2C12 myotubes (Fig. 17f, 
lower panel). The inhibition by the Erbin mutant lacking the MuSK binding domain was 
slightly weaker (Fig. 17f, lower panel). Surprisingly, the MuSK binding domain alone 
inhibited activation of the AChR ε- subunit reporter as observed with hErbin-v2 (Fig. 17f, 
lower panel). We asked whether the Erbin variants have a different impact on the 
transcription of the AChR ε-subunit reporter gene in C2C12 myoblasts. While hErbin-v2 
and Erbin∆MuSK-bd still inhibited AChR ε-subunit reporter gene transcription, Erbin 
MuSK-bd did not inhibit the reporter at all (Fig. 17f, upper panel). 
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Fig. 7: Erbin interacts concomitantly with MuSK and ErbB2. 
(a) Scheme of full length mouse Erbin and mutants thereof. The carboxy-terminal area is 
encoded by exons 21 to 26. Below this scheme, mouse or human Erbin variants lacking 
different exons are depicted. Other drawn human Erbin variants only consist of the 
MuSK binding domain or the PDZ domain. (b) Expression of these different mouse and 
human Erbin variants, as presented in (a) was ascertained by Western blot. (c) 
Precipitation of the human Erbin MuSK binding domain using transiently tranfected 
HEK293 cells co-precipitates full length MuSK as shown by Western blot. (d) Extracts 
from transiently transfected HEK293 cells expressing different Erbin variants were used 
for co-immunoprecipitation studies. Precipitates were analyzed for the presence of full 
length MuSK by Western blot. Note, precipitation of a human Erbin mutant which does 
not contain the MuSK binding domain is unable to co-precipitate MuSK (e) GST fusions 
of either human Erbin-N∆-1007, Erbin-PDZ, or Erbin-∆PDZ, immobilized on Glutathione 
beads, were incubated with HEK293 cell extracts containing full length ErbB2 and MuSK 
in different combinations, as indicated, and bound proteins were analyzed by Western 
blot. Note, GST-hErbin-PDZ pulls down ErbB2 but not MuSK, while GSThErbin-∆PDZ 
pulls down MuSK but not ErbB2. Further, the specificity of this binding was 
demonstrated by addition of either human Erbin-PDZ or Erbin-MuSK-bd which inhibits 
the pull down of either ErbB2 or MuSK, respectively. (f) To investigate if over-expression 
of Erbin variants in C2C12 cells affects ErbB- and MuSK-dependent gene expression, 
the cells were transfected in duplicate three independent times by a human type of 
Erbin-v2, Erbin-∆MuSK-bd, or Erbin-MuSK-bd together with an AChRε-luciferase 
reporter. Luciferase activities were 
 
4.3.7. Erbin enhances aggregation of AChRs in vivo 
Previously, Erbin was shown to interact with ErbB2 and to be enriched at the NMJ (Borg 
et al., 2000; Huang et al., 2001). Having identified Erbin interacting with MuSK thereby 
linking MuSK with ErbB2, we aimed to investigate the biological significance for an 
interaction between Erbin and MuSK. To this end, we set up experiments to investigate 
if ablation or over-expression of Erbin affects AChR clustering. First, we designed 
several different plasmid-derived shRNAproducing vectors and demonstrated their 
efficiency to knock down Erbin transcript levels. As examined by luciferase reporter 
assays, one of the shRNA species reduced the amount of Erbin transcript by approx. 
80% (Fig. 18a). Co-transfection of Erbin expression- and Erbin shRNAplasmids in 
HEK293 cells abolished Erbin protein expression almost completely (Fig. 18b). To 
examine the effect of different Erbin protein levels on AChR aggregation in muscle cells, 
we transiently transfected an Erbin expression-, or the Erbin shRNA- plasmid, together 
with pnlsGFP into C2C12 cells (Hashemolhosseini et al., 2000). After myotube 
formation, addition of nerve-derived agrin to the myotubes and staining with rhodamine-
labeled bungarotoxin, the influence of modulated Erbin protein amounts on AChR 
cluster formation was investigated. Surplus of Erbin did not influence AChR clustering 
(data not shown). Diminishing Erbin protein significantly reduced the density of 
aggregated AChR (Fig. 18d). If scrambled shRNA was transfected AChR aggregation 
was not affected (Fig. 18d). To find out if the size of AChR aggregates differs between 
muscle cells tranfected with Erbin- or scrambled shRNA, the length of the AChR 
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aggregates were compared to their area (Fig. 18e). No difference could be detected, 
arguing that the physical dimensions of AChR aggregates have not changed if Erbin 
was knocked down. On the other hand, comparing the mean fluorescence intensity of 
AChR aggregates with the length or area of AChR aggregates showed that knockdown 
of Erbin decreases the density of AChR aggregates (Fig. 18f, g). Altogether, we 
confirmed that aggregates formed in the absence of Erbin are in general of significantly 
less fluorescence intensity, as detected by confocal microscopy, reflecting in total a 
lower density of AChRs in the aggregates. To find out if AChR aggregates are 
disappearing faster in the absence of nerve-derived agrin and Erbin, we transiently 
transfected C2C12 cells with either an empty plasmid, scrambled shRNA, or Erbin 
shRNA, and measured the number of AChRs clusters remaining after removal of 
nervederived agrin (Fig. 18c). The number of remaining AChR clusters decreased with 
time independently of the presence or absence of agrin (Fig. 18c). 
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Fig. 8: Knockdown of Erbin reduces the density of AChR aggregates. 
(a) Luciferase activity assays using extracts from transiently transfected HEK293 cells 
demonstrate a reduction of Erbin mRNA upon treatment with an Erbin-specific shRNA, 
but not scrambled shRNA. Note, the Erbin-specific shRNA reduced the quantity of Erbin 
transcripts by more than 80%. (b) Diminished amount of Erbin protein by transfection of 
cells with shRNA was ascertained by Western blot. (c) To find out if AChR cluster 
stability decreased in the absence of Erbin, nerve-derived agrin was depleted from cell 
media and remaining AChR aggregates counted at the same time (pSuper, scramble, 
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Erbin-specific, n=76 / 67 / 70) or after, 4 (n=80 / 67 / 82) and 8 hours (n=71 / 72 / 79) 
and presented as % of remaining clusters. (d) C2C12 cells were transfected with shRNA 
(Erbin-specific or scrambled) cloned in pSuperGFPneo, differentiated to myotubes, and 
incubated with nerve-derived agrin. On the left, typical confocal images (compressed Z-
stack) are shown. On the right, high resolution gray scale images of AChR cluster of 
transfected and non-transfected myotubes are shown. Note that the AChR clusters 
formed in GFP-positive myotubes are less dense. Scale bar, 25 μm. (e) Comparison of 
areas of AChR clusters with their length as determined on C2C12 cells transiently 
transfected with either scrambled or Erbin-specific shRNA as indicated (n>20). (f, g) 
Mean fluorescence intensity of AChR clusters as described in (e) were plotted against 
AChR clusters length or area. Note, fluorescence intensity of AChR clusters was 
significantly lower if C2C12 cells which were transfected with Erbin-specific shRNA. A 
cluster was defined as an aggregation of AChRs with 
more then 10μm in length. 
 
4.3.8 Erbin associates ErbB2 with MuSK and TGF-β signalling at the NMJ 
Smad proteins are intracellular signaling mediators of TGF-β (ten Dijke and Heldin, 
2006). Recently, it was reported that Erbin inhibits TGF-β signaling through a novel 
Smad-interacting domain (Dai et al., 2007). We asked if C2C12 muscle cells express 
TGF-β receptors and Smad and if this happens in a nerve-derived agrin-dependent 
manner. We extracted total RNA from C2C12 myoblasts or from myotubes which were 
treated with muscle- or nerve-derived agrin. Using quantitative RT-PCR, we detected 
receptors TGF-βRI and TGF-βRII and Smad3 in C2C12 cells (Fig. 19a). Both TGF-β 
receptors and Smad3 are transcribed at higher amount in myotubes, and even higher in 
cells treated with nerve-derived agrin, compared to myotubes incubated with muscle-
derived agrin (Fig. 19a). To further assess the role of Erbin and MuSK in TGF-β 
signalling, we transiently transfected C2C12 cells with an expression plasmid encoding 
Smad3. As it was reported, Smad3 inhibited myotube formation from C2C12 myoblasts 
(Fig. 19b) (Liu et al., 2001). Co-transfection of the C2C12 cells with hErbin-v2, or hErbin-
v2 and MuSK, released this inhibition and cells differentiated and formed myotubes (Fig. 
19b). This finding is in agreement with previous data showing that increased Erbin 
expression in HEK293 cells physically sequesters, by its Smad-interacting domain, 
Smad2/Smad3 from their association with Smad4 and, thus, negatively modulates TGF-
β-dependent transcriptional responses and inhibition of cell growth (Dai et al., 2007). To 
verify the physiological consequence of the MuSK-Erbin-Smad interaction, the influence 
of Erbin alone or combined with MuSK on Smad2/Smad3-mediated transcriptional 
activation of TGF-β target genes was examined. Direct Smad2/Smad3-dependent 
transcription was investigated using the SBE4-Luc reporter, which contains four copies 
of a Smad binding site (Zawel et al., 1998). Transient transfection of C2C12 cells with 
Smad3 but not hErbin-v2 or MuSK led to a significant increase of luciferase activity (Fig. 
19c). If either hErbin-v2, MuSK, or both together were co-transfected with Smad3, less 
luciferase activity was detectable (Fig. 19c). These data implicate that MuSK, Erbin, or 
both together have no influence on activation of Smad3-dependent target promoters by 
themselves but inhibit partially Smad3-mediated transactivation of respective target 
genes.  
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Fig. 9: MuSK impinges on the modulation of TGF-β signalling by Erbin. 
(a) Expression profiles of TGF-β receptors I, II and Smad3 in C2C12 cells were 
examined by quantitative RT-PCRs and the results depicted as graphs. (b) C2C12 cells 
were transfected with GFPnls (Hashemolhosseini et al., 2000) together with Smad3, 
human Erbin-v2 and MuSK in different combinations. GFP-positive cells were counted in 
myoblasts and myotubes and their ratio presented as graph. Note, Smad3 inhibits 
C2C12 cell differentiation. Erbin sequesters Smad3 thereby ensuring C2C12 myotube 
formation. (c) Competition between Erbin binding either Smad3 or MuSK was studied by 
transfecting Smad3, human Erbin-v2, and MuSK, as indicated, together with a Smad3-
responsible reporter into C2C12 cells. Note, Smad3 strongly transactivates SBE4-Luc, 
while Erbin or MuSK transfected together with Smad3 resulted in less SBE4-Luc derived 
activity. 
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4.3.9 LAP family members like Lano and Scribble but not Densin-180 are 
expressed at the NMJ 
To find out if other LAP family members are expressed in muscle cells, we performed 
RT-PCR experiments with C2C12 myoblasts and myotubes incubated with muscle- or 
nerve-derived agrin. We detected PCR-amplified fragments from C2C12 cells for 
Scribble, Lano, but not Densin-180 arguing that Scribble and Lano are expressed in 
muscle cells (Fig. 20a). Next, we quantified transcript levels of Scribble and Lano in 
C2C12 cells. It turned out that Scribble is expressed at very high amounts compared to 
Lano in C2C12 cells and its transcription is even higher if C2C12 myotube were 
incubated with nerve-derived agrin compared to muscle-derived agrin (Fig. 20b). 
 
Fig. 10: Expression profile of other LAP protein family members in muscle cells. 
(a) RT-PCR data from C2C12 myoblasts and myotubes incubated with agrin as 
indicated. Note, Scribble and Lano, but not Densin-180, are expressed in C2C12 cells. 
(b) Expression profiling by quantitative RT-PCR demonstrated Scribble and Lano 
expression rather in myotubes than in myoblasts. A high expression profile for Scribble 
in C2C12 cells was detected, especially in myotubes and even more in nerve-derived 
agrin treated cells. 
 
5. Discussion 
Our data demonstrate for the first time an interaction between Erbin and the muscle-
specific receptor tyrosine kinase MuSK at the postsynaptic apparatus of the NMJ. Since 
MuSK bears a PDZ-binding domain at the very carboxy-terminus it was attractive to 
assume its interaction with the PDZ domain of Erbin thereby linking together both 
receptor tyrosine kinases ErbB2 and MuSK (Jean-Paul Borg, personal communication). 
Previous approaches failed to detect such an interaction because, as we present here, it 
is not the PDZ domain (aa 1280-1368) of human Erbin which interacts with the receptor 
tyrosine kinase MuSK. The area of Erbin which contacts MuSK is located at the 
carboxy-terminus of Erbin and is positioned between amino acids 1145 and 1229. In 
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close proximity to the MuSK binding domain of Erbin previously a WW (aa 973-977), two 
SH3 (aa1100-1104, 1115-1121) and the PDZ epitopes were identified (Borg et al., 
2000). Further, the MuSK binding domain of Erbin is part of a recently reported domain 
of Erbin involved in Smad3 binding (and is named SID, aa 1172-1282) (Dai et al., 2007). 
This is surprising as the overlapping binding domains of TGF-β and MuSK might 
implicate that their signaling cross-talks at the NMJ. Different TGF-β members and their 
receptors were found at the vertebrate NMJ but not much is known about their role at 
the postsynaptic apparatus (McLennan and Koishi, 1994; Jiang et al., 2000). Previously, 
TGF-β members were postulated to control the onset of secondary myotube formation 
by preventing the fusion of late myoblasts (Sanchez and Robbins, 1994). All three 
known members of TGF-β (1 to 3) were independently knocked out in mice, but turned 
out not to be involved in the onset of myotube formation (TGF-β1), or the skeletal 
muscles of the knockout mice were not studied in detail (Kaartinen et al., 1995; Proetzel 
et al., 1995; Sanford et al., 1997; McLennan et al., 2000). TGF-β2 was reported to be 
expressed in motoneurons were it is up-regulated after nerve injury (Jiang et al., 2000). 
All this is in contrast to invertebrate NMJs were p.ex. TGF-β signalling is known to play 
an essential role for the development of the Drosophila NMJ (Packard et al., 2003). It 
was found that TGF-type I receptor Saxophone and the downstream transcription factor 
Mothers against dpp are essential for the normal structural and functional formation of 
the Drosophila NMJ (Rawson et al., 2003). It was postulated that alternative TGF-β like 
factors might be also involved in vertebrate neuromuscular synapse formation (Packard 
et al., 2003). We followed up this question and identified TGF-β receptors and Smad3 
being expressed in myoblasts, up-regulated in myotubes, significantly stronger if they 
were incubated with nerve-derived agrin. Further, our studies narrowed down the MuSK 
binding domain of Erbin to an epitope encoded by exon 21. It seemed unlikely to 
assume that the MuSK binding domain is encoded by two exons 21 and 23 but not 22, 
because during evolution functional epitopes of proteins are in many cases known to be 
encoded and transmitted on single exons (Doolittle, 1995). Consequently, it might be 
speculated if the SID of Erbin really spans from exon 21 to 23, if it overlaps more 
precisely with the MuSK binding domain or if it is encoded only on exon 23. The 
detection of different splice variants of Erbin at the NMJ might help to answer this 
question since all splice variants detected contain exon 21, which in part encodes the 
MuSK binding domain, but two of them lack either exon 22, or both 22 and 23. In other 
words, these two splice variants might of Erbin interact in a Smad3- independent 
manner. Interestingly, the three different splice variants of Erbin detected in muscle cells 
are differentially regulated for their expression arguing that they might be required in 
different ways at the NMJ. To find out about competition of MuSK and Smad3 for the 
same binding site on Erbin, transient transfections of MuSK, Smad3, Erbin and a 
Smad3-dependent luciferase reporter (SBE4-luc) into C2C12 myotubes were performed. 
We expected to observe a higher luciferase activity if MuSK was co-transfected because 
it might compete for the domain of Erbin which interacts with MuSK and Smad3, thereby 
increasing the amount of available Smad3 for activation of the SBE4-luc reporter. But 
we failed to detect any competition between Smad3 and MuSK for the same binding site 
in Erbin arguing that MuSK did not sequestered Erbin thereby releasing Smad3. Further 
experiments should help to solve the question whether MuSK and TGF-β signalling 
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cross-talk together. We are aware that data presented here mark the beginning in 
understanding the biological role of LAP proteins at the NMJ. Knocking down Erbin, we 
observed a significant decrease of density of AChR aggregates. This change was 
unrelated to the physical dimensions of AChR aggregates. No difference between AChR 
aggregates of muscle cells tranfected with scrambled or Erbin-specific shRNA was 
observable if the length of the AChR aggregates were plotted against their area. It was 
obvious to test if there are other LAP family members expressed at the NMJ. Their 
presence might permit compensation of each other. Other LAP family members are 
p.ex. Densin- 180 (Apperson et al., 1996), Lano (Saito et al., 2001) and Scribble 
(Murdoch et al., 2003). Densin-180 is associated with postsynaptic density in rat brain 
and might be involved in localization of synaptic proteins (Huang et al., 2001). Scribble 
is a junctional protein involved in establishment and maintenance of epithelial cell 
polarity (Navarro et al., 2005). In fact, we could detect next to Erbin, Lano and Scribble 
but not Densin-180 at the NMJ. All three LAP proteins are expressed at significantly 
higher rates in myotubes compared to myoblasts. It turned out that our quantitative RT-
PCR data about the localization of Erbin transcripts in C2C12 myotubes treated with 
muscle- and nerve-derived agrin did not perfectly reflect the synaptic and extra-synaptic 
localization of their transcripts in muscle tissue. While the quantitative RT-PCR data only 
indicate an increase of Erbin transcripts in C2C12 cells incubated with nerve-derived 
agrin compared to myotubes treated with muscle-derived agrin, in situ hybridization of 
diaphragm tissue convincingly prove only restricted synaptic expression of Erbin at the 
NMJ. Accordingly, our presented quantitative RT-PCR data about the expression profile 
of Scribble and Lano do not exclude restricted synaptic expression of both. Here, we 
demonstrate that (1) Scribble is expressed in cultured muscle cells approx. 6-fold higher 
compared to its family members Erbin and Lano, (2) expression of Scribble is most up-
regulated if myotubes were incubated with nerve-derived agrin. Additional experiments 
are necessary to find out, (1) if Scribble and Lano also interact with either MuSK, Erbin 
or both, (2) if knockdown of all three LAP proteins will end in complete failure of AChR 
aggregation, and (3) what will be the phenotype of mice if all LAP genes present in 
muscle cells will be knocked out. Our data support the view that balanced physiological 
amounts of LAP family members play a crucial role at the NMJ. 
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7. Appendice 
7.1.1 Laboratori frequentati 
I laboratori presso cui si è svolta la mia attività di ricerca, sono: 
1. Dipartimento di Biochimica e Biotecnologie Mediche (DBBM) 
    II Policlinico – Università Federico II 
    Via S.Pansini, 5  
    80131 Napoli, Italy 
    Docente - guida: Prof.ssa Gabriella Esposito 
2. Institute of Biochemistry “E. Fischer” 
    Department of Neurobiology 
    University of Erlangen – Nuernberg 
    Fahrstrasse, 17 
    91054 Erlangen, Germany  
    Periodo di lavoro: Da Gennaio 2008 a Dicembre 2008 
 
  
